|
US3121076A
(en)
*
|
|
1964-02-11 |
|
Benzodiazepinones and processes |
|
US58665A
(en)
|
|
1866-10-09 |
|
Improvement in the manufacture of spoons |
|
US666073A
(en)
|
1900-10-29 |
1901-01-15 |
Harry Simmons |
Sectional legal-blank file.
|
|
GB235187A
(en)
|
1924-06-07 |
1926-06-03 |
Robert Howe Gould |
Improvements in burglar and like alarms
|
|
US1873732A
(en)
|
1928-12-28 |
1932-08-23 |
Abbott Lab |
Bactericide applicable to acid-fast bacteria
|
|
US3136815A
(en)
*
|
1959-12-10 |
1964-06-09 |
Hoffmann La Roche |
Amino substituted benzophenone oximes and derivatives thereof
|
|
US3371085A
(en)
|
1959-12-10 |
1968-02-27 |
Hoffmann La Roche |
5-aryl-3h-1,4-benzodiazepin-2(1h)-ones
|
|
US3454554A
(en)
|
1960-10-14 |
1969-07-08 |
Colgate Palmolive Co |
Aminoalkyliminodibenzyl compounds
|
|
US3116203A
(en)
|
1962-03-14 |
1963-12-31 |
Hoffmann La Roche |
Oleaginous systems
|
|
NL298071A
(cg-RX-API-DMAC7.html)
*
|
1963-06-04 |
|
|
|
|
CH449645A
(de)
|
1963-07-09 |
1968-01-15 |
Ciba Geigy |
Verfahren zur Herstellung neuer Aminosäuren
|
|
CH427803A
(de)
*
|
1963-12-06 |
1967-01-15 |
Geigy Ag J R |
Verfahren zur Herstellung eines neuen Isoxazolderivates
|
|
NL129434C
(cg-RX-API-DMAC7.html)
|
1966-03-12 |
|
|
|
|
US3397209A
(en)
|
1966-11-25 |
1968-08-13 |
Geigy Chem Corp |
3-hydroxy-5-isoxazole-carboxamide
|
|
US3885046A
(en)
|
1969-12-04 |
1975-05-20 |
Burroughs Wellcome Co |
Meta chloro or fluoro substituted alpha-T-butylaminopropionphenones in the treatment of depression
|
|
BE759838A
(fr)
|
1969-12-04 |
1971-06-03 |
Wellcome Found |
Cetones a activite biologique
|
|
FR2077918B1
(cg-RX-API-DMAC7.html)
|
1970-02-24 |
1973-04-06 |
Berthier Laboratoires |
|
|
US3821249A
(en)
|
1970-03-13 |
1974-06-28 |
En Nom Collectif Science Union |
Dibenzothiazefin derivatives
|
|
US3758528A
(en)
|
1970-03-13 |
1973-09-11 |
Science Union & Cie |
Tricyclic compounds
|
|
US3819631A
(en)
|
1970-12-15 |
1974-06-25 |
May & Baker Ltd |
Azapurinones
|
|
OA04285A
(fr)
|
1972-01-07 |
1979-12-31 |
Rhone Poulenc Sa |
Nouveaux dérivés de la pyrrolo (3,4-b) pyrazine et leur préparation.
|
|
USRE31617E
(en)
|
1972-02-04 |
1984-06-26 |
Bristol-Myers Company |
Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
|
|
US3932407A
(en)
|
1973-11-19 |
1976-01-13 |
Bristol-Myers Company |
Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
|
|
US4036840A
(en)
|
1972-06-07 |
1977-07-19 |
Icn Pharmaceuticals |
2-Substituted-s-triazolo[1,5a]pyrimidines
|
|
GB1457873A
(en)
|
1973-01-04 |
1976-12-08 |
Allen & Hanburys Ltd |
Imidazotriazines
|
|
GB1422263A
(en)
|
1973-01-30 |
1976-01-21 |
Ferrosan As |
4-phenyl-piperidine compounds
|
|
US4051236A
(en)
|
1973-02-15 |
1977-09-27 |
E. R. Squibb & Sons, Inc. |
Inhibition of blood platelet aggregation
|
|
US4314081A
(en)
|
1974-01-10 |
1982-02-02 |
Eli Lilly And Company |
Arloxyphenylpropylamines
|
|
US4194009A
(en)
|
1974-01-10 |
1980-03-18 |
Eli Lilly And Company |
Aryloxyphenylpropylamines for obtaining a psychotropic effect
|
|
US4280957A
(en)
*
|
1974-09-11 |
1981-07-28 |
Hoffmann-La Roche Inc. |
Imidazodiazepines and processes therefor
|
|
AR208414A1
(es)
|
1974-11-07 |
1976-12-27 |
Rhone Poulenc Ind |
Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2)
|
|
US4093617A
(en)
|
1974-11-12 |
1978-06-06 |
Icn Pharmaceuticals, Inc. |
3,5,7-Trisubstituted pyrazolo[1,5-a]pyrimidines
|
|
DE2460891C2
(de)
|
1974-12-21 |
1982-09-23 |
Gödecke AG, 1000 Berlin |
1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
US3960927A
(en)
|
1975-03-18 |
1976-06-01 |
Richardson-Merrell Inc. |
Olefinic derivatives of amino acids
|
|
NL7503310A
(nl)
|
1975-03-20 |
1976-09-22 |
Philips Nv |
Verbindingen met antidepressieve werking.
|
|
NL189199C
(nl)
|
1975-04-05 |
1993-02-01 |
Akzo Nv |
Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
|
|
GB1497306A
(en)
|
1975-07-03 |
1978-01-05 |
Leo Ab |
Preparation of lofepramine and its hydrochloride
|
|
FR2319338A1
(fr)
|
1975-08-01 |
1977-02-25 |
Synthelabo |
Nouveaux derives de a- phenyl benzylideniques des acides amines, leur preparation et les medicaments qui en contiennent
|
|
GB1526331A
(en)
|
1976-01-14 |
1978-09-27 |
Kefalas As |
Phthalanes
|
|
YU96177A
(en)
|
1976-04-24 |
1982-08-31 |
Wuelfing Johann A |
Process for obtaining adenine derivatives
|
|
USRE30511E
(en)
|
1977-02-03 |
1981-02-10 |
American Cyanamid Company |
Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones
|
|
US4107307A
(en)
|
1977-02-03 |
1978-08-15 |
American Cyanamid Company |
Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones
|
|
US4404380A
(en)
|
1977-02-14 |
1983-09-13 |
Mead Johnson & Company |
Triazolopyrimidines
|
|
CA1095906A
(en)
|
1977-02-14 |
1981-02-17 |
Davis L. Temple, Jr. |
Heterocyclopyrimidines, compositions and therapeutic process
|
|
US4096257A
(en)
|
1977-05-23 |
1978-06-20 |
American Cyanamid Company |
Substituted imidazo [1,2-d]-as-triazines
|
|
US4107309A
(en)
|
1977-05-23 |
1978-08-15 |
American Cyanamid Company |
Substituted imidazo[1,2-d]-as-triazines
|
|
IN148482B
(cg-RX-API-DMAC7.html)
|
1977-06-03 |
1981-03-07 |
Pfizer |
|
|
DK270378A
(da)
*
|
1977-06-20 |
1978-12-21 |
Krogsgaard Larsen P |
Isoxazolderivater
|
|
US4370328A
(en)
|
1977-11-03 |
1983-01-25 |
Pfizer Inc. |
Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
|
|
CA1086735A
(en)
|
1977-11-03 |
1980-09-30 |
John C. Danilewicz |
Piperidino-quinazolines
|
|
IL56369A
(en)
|
1978-01-20 |
1984-05-31 |
Erba Farmitalia |
Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
|
|
US4146718A
(en)
|
1978-04-10 |
1979-03-27 |
Bristol-Myers Company |
Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides
|
|
US4366156A
(en)
|
1979-03-05 |
1982-12-28 |
Mead Johnson & Company |
Antiallergic methods using diazaheterocyclopurines
|
|
CA1143728A
(en)
|
1979-10-04 |
1983-03-29 |
Max Gerecke |
Imidazodiazepine derivatives
|
|
US4536518A
(en)
|
1979-11-01 |
1985-08-20 |
Pfizer Inc. |
Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
|
|
JPS5668695A
(en)
|
1979-11-10 |
1981-06-09 |
Sankyo Co Ltd |
Enzyme inhibitor griseolic acid and its preparation
|
|
US4642345A
(en)
|
1980-08-14 |
1987-02-10 |
Mead Johnson & Company |
6,7-dihydro-3H-imidazo[1,2-a]-purine-9(4H)-ones
|
|
US4301176A
(en)
|
1980-08-18 |
1981-11-17 |
Warner-Lambert Company |
Method of administering calcium valproate
|
|
US4361583A
(en)
|
1980-08-19 |
1982-11-30 |
Synthelabo |
Analgesic agent
|
|
FR2492258A1
(fr)
|
1980-10-17 |
1982-04-23 |
Pharmindustrie |
Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
|
|
FR2492382A1
(fr)
|
1980-10-22 |
1982-04-23 |
Synthelabo |
Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
|
|
US4489078A
(en)
|
1980-11-24 |
1984-12-18 |
Mead Johnson & Company |
Diazaheterocyclopurines used as anti-broncho spasmatics and vasodilators
|
|
US4338317A
(en)
|
1981-03-16 |
1982-07-06 |
Mead Johnson & Company |
Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
|
|
US4383999A
(en)
*
|
1981-05-26 |
1983-05-17 |
Smithkline Beckman Corporation |
Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
|
|
FR2508035A1
(fr)
|
1981-06-23 |
1982-12-24 |
Fabre Sa Pierre |
Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
|
|
LU83729A1
(fr)
|
1981-11-04 |
1983-09-01 |
Galephar |
Sels d'acide valproique,leur preparation et leur utilisation
|
|
US4513135A
(en)
|
1982-03-05 |
1985-04-23 |
Eli Lilly And Company |
Diaryl-pyrazine derivatives affecting GABA binding
|
|
CH655110A5
(de)
|
1982-09-03 |
1986-03-27 |
Otsuka Pharma Co Ltd |
Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
|
|
US4663320A
(en)
|
1983-02-16 |
1987-05-05 |
Syntex (U.S.A.) Inc. |
(2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
|
|
US4490371A
(en)
|
1983-02-16 |
1984-12-25 |
Syntex (U.S.A.) Inc. |
N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
|
|
US4521422A
(en)
|
1983-06-23 |
1985-06-04 |
American Cyanamid Company |
Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
|
|
US4900836A
(en)
*
|
1983-06-23 |
1990-02-13 |
American Cyanamid Company |
(3-amino-1H-pyrazol-4-yl) (aryl)methanones
|
|
US4626538A
(en)
|
1983-06-23 |
1986-12-02 |
American Cyanamid Company |
[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
|
|
US4513006A
(en)
|
1983-09-26 |
1985-04-23 |
Mcneil Lab., Inc. |
Anticonvulsant sulfamate derivatives
|
|
US4761501A
(en)
|
1983-10-26 |
1988-08-02 |
American Home Products Corporation |
Substituted phenylacetamides
|
|
US4593029A
(en)
|
1984-02-15 |
1986-06-03 |
Syntex (U.S.A.) Inc. |
Novel ω-(N-imidazolyl)alkyl ethers of 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
|
|
GB8425872D0
(en)
*
|
1984-10-12 |
1984-11-21 |
Ciba Geigy Ag |
Chemical compounds
|
|
US4855290A
(en)
|
1985-05-10 |
1989-08-08 |
State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research |
Derivatives of quinuclidine
|
|
DK288385D0
(da)
|
1985-06-26 |
1985-06-26 |
Novo Industri As |
Aminosyrederivater
|
|
DE3677316D1
(de)
|
1985-10-17 |
1991-03-07 |
Smith Kline French Lab |
4(4-oxo-1,4-dihydropyridin-1-yl)phenyl-derivate.
|
|
US4670434A
(en)
|
1985-11-14 |
1987-06-02 |
Syntex (U.S.A.) Inc. |
(2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
|
|
US4775674A
(en)
|
1986-05-23 |
1988-10-04 |
Bristol-Myers Company |
Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
|
|
FR2600650B1
(fr)
|
1986-06-27 |
1988-09-09 |
Synthelabo |
Procede de preparation d'imidazopyridines et composes intermediaires
|
|
US4701459A
(en)
|
1986-07-08 |
1987-10-20 |
Bristol-Myers Company |
7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
|
|
US5312840A
(en)
|
1986-07-10 |
1994-05-17 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education |
Substituted guanidines having high binding to the sigma receptor and the use thereof
|
|
US5093525A
(en)
|
1986-07-10 |
1992-03-03 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
|
|
US4709094A
(en)
|
1986-07-10 |
1987-11-24 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon |
Sigma brain receptor ligands and their use
|
|
US5385946A
(en)
|
1986-07-10 |
1995-01-31 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon |
Method for treating hypertension with disubstituted granidine compounds
|
|
US4761416A
(en)
|
1986-07-25 |
1988-08-02 |
Syntex (U.S.A.) Inc. |
N-N-disubstituted-ω-[2-amino-3-(carbonylmethyl)-3, 4-dihydroquinazolinyl]oxyalkylamides and related compounds
|
|
US4739056A
(en)
|
1986-11-26 |
1988-04-19 |
Syntex (U.S.A.) Inc. |
N-N-disubstituted-omega-(2-amino-3-(carbonylmethyl)-3,4-dihydroquinazolinyl)oxy-alkylamides and related compounds
|
|
US4786648A
(en)
|
1986-12-08 |
1988-11-22 |
Warner-Lambert Company |
O-substituted tetrahydropyridine oxime cholinergic agents
|
|
US4710508A
(en)
|
1986-12-08 |
1987-12-01 |
Warner-Lambert Company |
O-substituted tetrahydropyridine oxime cholinergic agents
|
|
US4956388A
(en)
|
1986-12-22 |
1990-09-11 |
Eli Lilly And Company |
3-aryloxy-3-substituted propanamines
|
|
US4721784A
(en)
|
1986-12-22 |
1988-01-26 |
Ortho Pharmaceutical Corporation |
6-benzoxazinyl-2,3,4,5-tetrahydropyridazin-3-ones
|
|
US5081242A
(en)
|
1986-12-22 |
1992-01-14 |
Ortho Pharmaceutical Corporation |
6-benzoxazinyl- and 6-benzothiazinyl 2,3,4,5-tetrahydropyridazin-3-ones
|
|
US4766118A
(en)
|
1986-12-22 |
1988-08-23 |
Ortho Pharmaceutical Corporation |
6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5-tetrahydropyridazin-3-ones and pharmaceutical use
|
|
US4929734A
(en)
|
1987-03-31 |
1990-05-29 |
Warner-Lambert Company |
Tetrahydropyridine oxime compounds
|
|
GB8714789D0
(en)
|
1987-06-24 |
1987-07-29 |
Lundbeck & Co As H |
Heterocyclic compounds
|
|
US4981858A
(en)
|
1987-08-13 |
1991-01-01 |
State Of Israel, Represented By The Prime Minister's Office, Israel Institute For Biological Research |
Optical isomers
|
|
US5120723A
(en)
|
1987-08-25 |
1992-06-09 |
University Of Southern California |
Method, compositions, and compounds for modulating brain excitability
|
|
US5232917A
(en)
*
|
1987-08-25 |
1993-08-03 |
University Of Southern California |
Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
|
|
USRE35517E
(en)
|
1987-08-25 |
1997-05-20 |
University Of Southern California |
Method, compositions, and compounds for modulating brain excitability
|
|
US5319115A
(en)
|
1987-08-25 |
1994-06-07 |
Cocensys Inc. |
Method for making 3α-hydroxy, 3β-substituted-pregnanes
|
|
ATE122353T1
(de)
|
1987-10-05 |
1995-05-15 |
Yamanouchi Pharma Co Ltd |
Heterozyklische spiroverbindungen und ihre herstellung.
|
|
US5412096A
(en)
|
1987-10-05 |
1995-05-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Hydrochloride salts of heterocyclic spiro compounds
|
|
IL88156A
(en)
|
1987-11-13 |
1997-02-18 |
Novo Nordisk As |
Azacyclic compounds their preparation and pharmaceutical compositions containing them
|
|
US4831031A
(en)
|
1988-01-22 |
1989-05-16 |
Pfizer Inc. |
Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
|
|
US5091431A
(en)
|
1988-02-08 |
1992-02-25 |
Schering Corporation |
Phosphodiesterase inhibitors
|
|
US4957916A
(en)
|
1988-08-05 |
1990-09-18 |
Janssen Pharmaceutica N.V. |
Antipsychotic 3-piperazinylbenzazole derivatives
|
|
GB8820266D0
(en)
|
1988-08-26 |
1988-09-28 |
Smith Kline French Lab |
Compounds
|
|
US4861891A
(en)
|
1988-08-31 |
1989-08-29 |
Pfizer Inc. |
Antidepressant N-substituted nicotinamide compounds
|
|
FR2636625B1
(fr)
|
1988-09-01 |
1990-11-09 |
Jouveinal Sa |
Benzylamines disubstituees, leur procede de preparation, leur utilisation comme medicament et leurs intermediaires de synthese
|
|
DE3839385A1
(de)
|
1988-11-22 |
1990-05-23 |
Boehringer Ingelheim Kg |
Neue quinuclidine, ihre herstellung als arzneimittel und verfahren zu ihrer herstellung
|
|
US5286864A
(en)
|
1988-11-22 |
1994-02-15 |
Boehringer Ingelheim Kg |
Quinuclidines, their use as medicaments and processes for their preparation
|
|
US5043345A
(en)
|
1989-02-22 |
1991-08-27 |
Novo Nordisk A/S |
Piperidine compounds and their preparation and use
|
|
US4981870A
(en)
|
1989-03-07 |
1991-01-01 |
Pfizer Inc. |
Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
|
|
US4971972A
(en)
|
1989-03-23 |
1990-11-20 |
Schering Corporation |
Phosphodiesterase inhibitors having an optionally substituted purine derivative portion and a benzo- or cyclopenta-furan portion
|
|
US5278170A
(en)
|
1989-04-13 |
1994-01-11 |
Beecham Group P.L.C. |
Azabicylo oxime compounds
|
|
ATE269330T1
(de)
|
1989-04-13 |
2004-07-15 |
Beecham Group Plc |
Chemische verbindungen
|
|
DE69011859T2
(de)
|
1989-05-02 |
1994-12-15 |
Oregon State |
Verwendung von sigma-rezeptor-liganden zur herstellung eines anxiolytikums.
|
|
US4956368A
(en)
|
1989-07-24 |
1990-09-11 |
Bristol-Myers Company |
Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione
|
|
US5109002A
(en)
|
1989-09-08 |
1992-04-28 |
Du Pont Merck Pharmaceutical Company |
Antipsychotic 1-cycloalkylpiperidines
|
|
EP0497843A4
(en)
|
1989-10-27 |
1992-09-23 |
The Du Pont Merck Pharmaceutical Company |
(n-phthalimidoalkyl) piperidines
|
|
US4943573A
(en)
|
1989-11-01 |
1990-07-24 |
Bristol-Myers Squibb Company |
Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
|
|
US5010086A
(en)
|
1990-02-28 |
1991-04-23 |
Sterling Drug Inc. |
Imidazopyridines, compositions and use
|
|
US4963561A
(en)
|
1990-02-28 |
1990-10-16 |
Sterling Drug Inc. |
Imidazopyridines, their preparation and use
|
|
US5149817A
(en)
|
1990-03-05 |
1992-09-22 |
Shionogi & Co., Ltd. |
Teirahydropyridine derivatives
|
|
US5169855A
(en)
|
1990-03-28 |
1992-12-08 |
Du Pont Merck Pharmaceutical Company |
Piperidine ether derivatives as psychotropic drugs or plant fungicides
|
|
US5116995A
(en)
|
1990-05-25 |
1992-05-26 |
Taisho Pharmaceutical Co., Ltd. |
Carbazole compounds
|
|
JPH05508836A
(ja)
|
1990-05-25 |
1993-12-09 |
オレゴン州 |
シグマ受容体に対して高い結合性を有する置換グアニジンおよびその使用
|
|
US5612211A
(en)
|
1990-06-08 |
1997-03-18 |
New York University |
Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
|
|
FR2663328B1
(fr)
|
1990-06-14 |
1994-08-05 |
Sanofi Sa |
Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
US5250534A
(en)
|
1990-06-20 |
1993-10-05 |
Pfizer Inc. |
Pyrazolopyrimidinone antianginal agents
|
|
US5095015A
(en)
|
1990-07-24 |
1992-03-10 |
Neurogen Corporation |
Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands
|
|
FR2663934B1
(fr)
|
1990-06-27 |
1994-06-03 |
Adir |
Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.
|
|
JP2935541B2
(ja)
|
1990-06-28 |
1999-08-16 |
サントリー株式会社 |
縮合複素環化合物
|
|
US5086054A
(en)
|
1990-07-31 |
1992-02-04 |
Sri International |
Novel arylcycloalkanepolyalkylamines
|
|
DK198590D0
(da)
|
1990-08-21 |
1990-08-21 |
Novo Nordisk As |
Heterocykliske forbindelser, deres fremstilling og anvendelse
|
|
GB9019095D0
(en)
|
1990-09-01 |
1990-10-17 |
Beecham Group Plc |
Novel compounds
|
|
US5185446A
(en)
*
|
1990-09-04 |
1993-02-09 |
Neurogen Corporation |
Certain cycloalkyl imidazopyrimidines; a new class of gaba brainreceptor ligands
|
|
EP0738717A1
(en)
|
1990-10-09 |
1996-10-23 |
Neurogen Corporation |
Certain substituted pyrimidines as intermediates for production of cycloalkyl and azacycloalkyl pyrrolopyrimidines
|
|
EP0552213A1
(en)
|
1990-10-12 |
1993-07-28 |
Beecham Group Plc |
1,2,5,6-tetrahydropyridine oxime derivatives
|
|
EP0481262B1
(en)
|
1990-10-15 |
1995-02-15 |
Societe Des Produits Nestle S.A. |
Treatment of black tea
|
|
US5139802A
(en)
|
1990-10-15 |
1992-08-18 |
Nestec S.A. |
Oxidation of tea
|
|
US5130430A
(en)
|
1990-10-31 |
1992-07-14 |
Neurogen Corporation |
2-substituted imidazoquinoxaline diones, a new class of gaba brain receptor ligands
|
|
US5744602A
(en)
*
|
1990-10-31 |
1998-04-28 |
Neurogen Corporation |
Certain imidazoquinoxalines; a new class of GABA brain receptor ligands
|
|
US6268496B1
(en)
|
1990-10-31 |
2001-07-31 |
Neurogen Corporation |
Certain imidazoquinoxalines: a new class of GABA brain receptor ligands
|
|
US6197819B1
(en)
|
1990-11-27 |
2001-03-06 |
Northwestern University |
Gamma amino butyric acid analogs and optical isomers
|
|
US5116837A
(en)
|
1990-12-21 |
1992-05-26 |
Ortho Pharmaceutical Corporation |
2,9-dihydro-(6 or 7)-(3-oxo-2,3,4,5-tetrahydropyridazinyl)-pyrazolo [4,3-B]-1,4-benzoxazines
|
|
FR2671800B1
(fr)
|
1991-01-17 |
1993-03-12 |
Rhone Poulenc Rorer Sa |
Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent.
|
|
US5180729A
(en)
|
1991-02-22 |
1993-01-19 |
Du Pont Merck Pharmaceutical Company |
Use of sigma receptor antagonists for treatment of cocaine abuse
|
|
US5162341A
(en)
|
1991-02-22 |
1992-11-10 |
Du Pont Merck Pharmaceutical Company |
Use of sigma receptor antagonists for treatment of amphetamine abuse
|
|
EP0503411B1
(de)
|
1991-03-14 |
1995-11-29 |
BASF Aktiengesellschaft |
Substituierte N-Phenylpiperidine und Arzneimittel daraus
|
|
US5231099A
(en)
|
1991-04-15 |
1993-07-27 |
Du Pont Merck Pharmaceutical Company |
Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs
|
|
US5137895A
(en)
|
1991-04-29 |
1992-08-11 |
A. H. Robins Company, Incorporated |
3-[N-aroyl(or thioaroyl)aminomethyl]-3-quinuclidinols
|
|
US5403931A
(en)
|
1991-05-15 |
1995-04-04 |
Yamanouchi Pharmaceutical Co., Ltd. |
(-)-(S)-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4.5]decane L-tartrate
|
|
US5719057A
(en)
*
|
1991-06-11 |
1998-02-17 |
Merck Sharpe & Dohme Ltd. |
Stably human transfected rodent fibroblast cell line expressing human GABA-A recepotors, and cloned human GABA-A receptor subunit CDNA sequences
|
|
NZ243065A
(en)
|
1991-06-13 |
1995-07-26 |
Lundbeck & Co As H |
Piperidine derivatives and pharmaceutical compositions
|
|
AU676993B2
(en)
|
1991-06-27 |
1997-04-10 |
Virginia Commonwealth University |
Sigma receptor ligands and the use thereof
|
|
US5182290A
(en)
|
1991-08-27 |
1993-01-26 |
Neurogen Corporation |
Certain oxazoloquinolinones; a new class of GABA brain receptor ligands
|
|
US5182386A
(en)
|
1991-08-27 |
1993-01-26 |
Neurogen Corporation |
Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands
|
|
CA2118938A1
(en)
|
1991-09-13 |
1993-04-01 |
Kelvin W. Gee |
Novel gabaa receptor with steroid binding sites
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
US5369108A
(en)
|
1991-10-04 |
1994-11-29 |
Sloan-Kettering Institute For Cancer Research |
Potent inducers of terminal differentiation and methods of use thereof
|
|
US5585490A
(en)
|
1991-10-08 |
1996-12-17 |
Neurogen Corporation |
Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of GABA brain receptor ligands
|
|
PH31245A
(en)
|
1991-10-30 |
1998-06-18 |
Janssen Pharmaceutica Nv |
1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
|
|
WO1993009094A1
(en)
|
1991-10-30 |
1993-05-13 |
The Du Pont Merck Pharmaceutical Company |
Ether derivatives of alkyl piperidines and pyrrolidines as antipsychotic agents
|
|
US5212310A
(en)
|
1991-12-19 |
1993-05-18 |
Neurogen Corporation |
Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands
|
|
US5243049A
(en)
*
|
1992-01-22 |
1993-09-07 |
Neurogen Corporation |
Certain pyrroloquinolinones: a new class of GABA brain receptor ligands
|
|
MX9300875A
(es)
|
1992-02-20 |
1993-08-31 |
Smithkline Beecham Plc |
Procedimiento para la preparacion de compuestos azabiciclicos.
|
|
US6225115B1
(en)
|
1992-03-04 |
2001-05-01 |
Synaptic Pharmaceutical Corporation |
DNA encoding taurine and GABA transporters and uses thereof
|
|
US5298657A
(en)
|
1992-03-20 |
1994-03-29 |
Cambridge Neuroscience Inc. |
Preparation of substituted guanidines
|
|
US5294612A
(en)
|
1992-03-30 |
1994-03-15 |
Sterling Winthrop Inc. |
6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
|
|
US5367077A
(en)
|
1992-04-08 |
1994-11-22 |
Neurogen Corporation |
Certain cycloalkyl and azacycloalkyl pyrrolopyridines; a new class of gaba rain receptor ligands
|
|
AU4117493A
(en)
|
1992-04-08 |
1994-11-21 |
Neurogen Corporation |
Certain aryl fused pyrrolopyrimidines; a new class of gaba brain receptor ligands
|
|
US5266698A
(en)
|
1992-04-30 |
1993-11-30 |
Neurogen Corporation |
Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands
|
|
ES2060547B1
(es)
|
1992-06-04 |
1995-06-16 |
Ferrer Int |
Mejoras en el objeto de la patente de invencion n/ 9201158 que se refiere a "procedimiento de obtencion de nuevos derivados de la 4-bencilpiperidina".
|
|
GB9212693D0
(en)
|
1992-06-15 |
1992-07-29 |
Celltech Ltd |
Chemical compounds
|
|
GB9212673D0
(en)
|
1992-06-15 |
1992-07-29 |
Celltech Ltd |
Chemical compounds
|
|
JP2683783B2
(ja)
|
1992-07-10 |
1997-12-03 |
雪印乳業株式会社 |
シェーグレン症候群治療剤
|
|
JP2657760B2
(ja)
|
1992-07-15 |
1997-09-24 |
小野薬品工業株式会社 |
4−アミノキナゾリン誘導体およびそれを含有する医薬品
|
|
US5928947A
(en)
|
1992-07-27 |
1999-07-27 |
California Institute Of Technology |
Mammalian multipotent neural stem cells
|
|
US5306819A
(en)
|
1992-08-27 |
1994-04-26 |
Neurogen Corporation |
Certain aryl a cycloalkyl fused imidazopyrazinols; and new class of GABA brain receptor ligands
|
|
ZA937382B
(en)
|
1992-10-06 |
1994-04-29 |
Warner Lambert Co |
Novel composition for peroral therapy of cognitionimpairment and a process therefor
|
|
GB9222253D0
(en)
|
1992-10-23 |
1992-12-09 |
Celltech Ltd |
Chemical compounds
|
|
US5668283A
(en)
|
1992-11-12 |
1997-09-16 |
Neurogen Corporation |
Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands
|
|
US5286860A
(en)
|
1992-11-12 |
1994-02-15 |
Neurogen Corporation |
Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands
|
|
US5814651A
(en)
|
1992-12-02 |
1998-09-29 |
Pfizer Inc. |
Catechol diethers as selective PDEIV inhibitors
|
|
WO1994013799A1
(en)
*
|
1992-12-10 |
1994-06-23 |
Merck Sharp & Dohme Limited |
Stably transfected cell lines expressing gaba-a receptors
|
|
GB9226830D0
(en)
|
1992-12-23 |
1993-02-17 |
Celltech Ltd |
Chemical compounds
|
|
US5622977A
(en)
|
1992-12-23 |
1997-04-22 |
Celltech Therapeutics Limited |
Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
|
|
AU5991294A
(en)
|
1993-01-06 |
1994-08-15 |
Neurogen Corporation |
Certain aryl substituted imidazopyrazinones a new class of gaba brain receptor ligands
|
|
US5362860A
(en)
|
1993-02-01 |
1994-11-08 |
Warner-Lambert Company |
Neutral stabilization complex for CI-979 HCl, a cognition activator
|
|
US5424301A
(en)
|
1993-02-01 |
1995-06-13 |
Warner-Lambert Company |
Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents
|
|
US6013799A
(en)
*
|
1993-03-03 |
2000-01-11 |
Neurogen Corporation |
Certain cycloalkyl imidazopyrimides, a new class of gaba brain receptor ligands
|
|
GB9304920D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
|
GB9304919D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
|
DK0690850T3
(da)
|
1993-03-26 |
1998-02-09 |
Schering Corp |
2-Substituerede morpholin- og thiomorpholinderivater som GABAB-antagonister
|
|
US5455252A
(en)
|
1993-03-31 |
1995-10-03 |
Syntex (U.S.A.) Inc. |
Optionally substituted 6,8-quinolines
|
|
JP4008024B2
(ja)
|
1993-05-24 |
2007-11-14 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
Gabaaレセプター複合体と相互作用させるための化合物
|
|
US5750702A
(en)
|
1993-10-27 |
1998-05-12 |
Neurogen Corporation |
Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands
|
|
JP3610368B2
(ja)
|
1993-05-27 |
2005-01-12 |
セネス リミティド |
治療用置換グアニジン
|
|
GB9301192D0
(en)
|
1993-06-09 |
1993-06-09 |
Trott Francis W |
Flower shaped mechanised table
|
|
AU7177694A
(en)
|
1993-06-23 |
1995-01-17 |
Cambridge Neuroscience, Inc. |
Sigma receptor ligands and the use thereof
|
|
CZ290266B6
(cs)
|
1993-07-02 |
2002-06-12 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Substituované benzamidy, způsob jejich výroby a farmaceutické prostředky s jejich obsahem
|
|
WO1995001997A1
(en)
|
1993-07-09 |
1995-01-19 |
Smithkline Beecham Corporation |
RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
|
|
ES2074946B1
(es)
|
1993-07-19 |
1996-06-16 |
Ferrer Int |
Nuevos compuestos derivados de la 1,2-etanodiamina-n,n,n',n'-tetrasustituida.
|
|
WO1995004050A1
(en)
|
1993-07-28 |
1995-02-09 |
Santen Pharmaceutical Co., Ltd. |
Novel 1,4-di(phenylalkyl)piperazine derivative
|
|
US5665754A
(en)
|
1993-09-20 |
1997-09-09 |
Glaxo Wellcome Inc. |
Substituted pyrrolidines
|
|
US5484944A
(en)
*
|
1993-10-27 |
1996-01-16 |
Neurogen Corporation |
Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands
|
|
CZ283564B6
(cs)
|
1993-11-26 |
1998-05-13 |
Pfizer Inc. |
3-Aryl-2-isoxazolin-5-hydroxamové kyseliny a farmaceutické prostředky na jejich bázi
|
|
US5502072A
(en)
|
1993-11-26 |
1996-03-26 |
Pfizer Inc. |
Substituted oxindoles
|
|
JP2818820B2
(ja)
|
1993-11-26 |
1998-10-30 |
ファイザー・インク. |
抗炎症剤としての3−アリール−2−イソオキサゾリン類
|
|
US5849760A
(en)
|
1993-12-09 |
1998-12-15 |
Institut De Recherche Jouveinal |
2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors
|
|
US5500420A
(en)
|
1993-12-20 |
1996-03-19 |
Cornell Research Foundation, Inc. |
Metabotropic glutamate receptor agonists in the treatment of cerebral ischemia
|
|
EP0738268B1
(en)
|
1993-12-22 |
2004-03-03 |
Celltech R&D Limited |
Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
|
|
GB9326699D0
(en)
|
1993-12-22 |
1994-03-02 |
Celltech Ltd |
Chemical compounds
|
|
GB9326173D0
(en)
|
1993-12-22 |
1994-02-23 |
Celltech Ltd |
Chemical compounds and process
|
|
US7060450B1
(en)
|
1993-12-30 |
2006-06-13 |
President And Fellows Of Harvard College |
Screening assays for agonists and antagonists of the hedgehog signaling pathway
|
|
GB9514465D0
(en)
|
1995-07-14 |
1995-09-13 |
Glaxo Lab Sa |
Chemical compounds
|
|
GB9401090D0
(en)
|
1994-01-21 |
1994-03-16 |
Glaxo Lab Sa |
Chemical compounds
|
|
US5939545A
(en)
|
1994-02-14 |
1999-08-17 |
Cocensys, Inc. |
Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
|
|
DK1038880T3
(da)
|
1994-02-14 |
2008-03-03 |
Euro Celtique Sa |
Androstaner og pregnaner til allosterisk modulering af GABA-receptor
|
|
US5783575A
(en)
|
1994-03-14 |
1998-07-21 |
Novo Nordisk A/S |
Antagonists, their preparation and use
|
|
US5696148A
(en)
|
1994-03-14 |
1997-12-09 |
Novo Nordisk A/S |
Indole compounds and their use in treating diseases of the central nervous system
|
|
CZ265096A3
(en)
|
1994-03-14 |
1997-06-11 |
Novo Nordisk As |
Thienoindole derivatives, their use, process of their preparation and pharmaceutical composition containing thereof
|
|
US5637617A
(en)
|
1994-04-01 |
1997-06-10 |
The Regents Of The University Of California |
Methods for use of GABAa receptor GABAergic compounds
|
|
GB9409705D0
(en)
|
1994-05-14 |
1994-07-06 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9410877D0
(en)
|
1994-05-31 |
1994-07-20 |
Bayer Ag |
Heterocyclycarbonyl substituted benzoduranyl-and-thiophenyl-alkanecarboxyclic acid derivatives
|
|
US6245774B1
(en)
|
1994-06-21 |
2001-06-12 |
Celltech Therapeutics Limited |
Tri-substituted phenyl or pyridine derivatives
|
|
US5786354A
(en)
|
1994-06-21 |
1998-07-28 |
Celltech Therapeutics, Limited |
Tri-substituted phenyl derivatives and processes for their preparation
|
|
GB9412573D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
|
GB9412571D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
|
GB9412672D0
(en)
|
1994-06-23 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
|
JP2852608B2
(ja)
|
1994-06-27 |
1999-02-03 |
雪印乳業株式会社 |
口腔乾燥症治療剤
|
|
US5750566A
(en)
|
1994-08-12 |
1998-05-12 |
Eli Lilly And Company |
Synthetic excitatory amino acids
|
|
WO1996006843A1
(en)
|
1994-08-29 |
1996-03-07 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel naphthyridine derivative and medicinal composition thereof
|
|
WO1996010570A1
(en)
|
1994-09-30 |
1996-04-11 |
Pfizer Inc. |
NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
|
|
GB9420010D0
(en)
|
1994-10-01 |
1994-11-16 |
Marck Sharp & Dohme Limited |
Nucleic acids
|
|
US5554645A
(en)
|
1994-10-03 |
1996-09-10 |
Mars, Incorporated |
Antineoplastic cocoa extracts and methods for making and using the same
|
|
DE4436509A1
(de)
|
1994-10-13 |
1996-04-18 |
Hoechst Schering Agrevo Gmbh |
Substituierte Spiroalkylamino- und alkoxy-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide
|
|
JP3993651B2
(ja)
|
1994-10-21 |
2007-10-17 |
アスビオファーマ株式会社 |
シクロプロパクロメンカルボン酸誘導体
|
|
US5473077A
(en)
|
1994-11-14 |
1995-12-05 |
Eli Lilly And Company |
Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists
|
|
BR9509764A
(pt)
|
1994-11-23 |
1998-07-07 |
Cocensys Inc |
Série androstano e pregnano para modulação alostérica de receptor de gaba
|
|
GB9423911D0
(en)
|
1994-11-26 |
1995-01-11 |
Pfizer Ltd |
Therapeutic agents
|
|
GB9423910D0
(en)
|
1994-11-26 |
1995-01-11 |
Pfizer Ltd |
Therapeutic agents
|
|
GB9503601D0
(en)
|
1995-02-23 |
1995-04-12 |
Merck Sharp & Dohme |
Method of treatment and method of manufacture of medicament
|
|
CA2189355A1
(en)
|
1995-03-01 |
1996-09-06 |
Yasuo Onoda |
Imidazoquinazoline derivatives
|
|
US5488055A
(en)
|
1995-03-10 |
1996-01-30 |
Sanofi Winthrop Inc. |
Substituted N-cycloalkylmethyl-1H-pyrazolo(3,4-b)quinolin-4 amines and compositions and methods of use thereof
|
|
CA2218493C
(en)
*
|
1995-04-21 |
2005-02-22 |
Neurosearch A/S |
Benzimidazole compounds and their use as modulators of the gabaa receptor complex
|
|
JPH11504905A
(ja)
*
|
1995-05-05 |
1999-05-11 |
ノボ ノルディスク アクティーゼルスカブ |
新規複素環の化学
|
|
DE19518082A1
(de)
|
1995-05-17 |
1996-11-21 |
Merck Patent Gmbh |
4(-Arylaminomethylen)-2,4-dihydropyrazol-3-one
|
|
PT828728E
(pt)
|
1995-05-18 |
2003-06-30 |
Altana Pharma Ag |
Di-hidrobenzofuranos de fenilo
|
|
ATE230404T1
(de)
|
1995-05-18 |
2003-01-15 |
Altana Pharma Ag |
Cyclohexyldihydrobenzofurane
|
|
US6514996B2
(en)
|
1995-05-19 |
2003-02-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Derivatives of benzofuran or benzodioxole
|
|
US5637724A
(en)
*
|
1995-06-05 |
1997-06-10 |
Neurogen Corporation |
Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands
|
|
US5637725A
(en)
|
1995-06-05 |
1997-06-10 |
Neurogen Corporation |
Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands
|
|
PT837874E
(pt)
*
|
1995-06-06 |
2005-03-31 |
Euro Celtique Sa |
Esteroides neuroactivos da serie androstano e pregnano
|
|
US5534522A
(en)
|
1995-06-07 |
1996-07-09 |
Warner-Lambert Company |
(R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent
|
|
US5910590A
(en)
|
1995-06-07 |
1999-06-08 |
Neurogen Corporation |
Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands
|
|
GB9514464D0
(en)
|
1995-07-14 |
1995-09-13 |
Glaxo Lab Sa |
Medicaments
|
|
EP0850215B1
(en)
|
1995-07-26 |
2000-10-18 |
Pfizer Inc. |
N-(aroyl)glycine hydroxamic acid derivatives and related compounds
|
|
US20010018074A1
(en)
|
1995-07-29 |
2001-08-30 |
Smithkline Beecham P.L.C. |
Process for preparing solid dosage forms of very low-dose drugs
|
|
AU6514196A
(en)
|
1995-07-31 |
1997-02-26 |
Novo Nordisk A/S |
Heterocyclic compounds, their preparation and use
|
|
DE19533975A1
(de)
|
1995-09-14 |
1997-03-20 |
Merck Patent Gmbh |
Arylalkyl-diazinone
|
|
US6166041A
(en)
|
1995-10-11 |
2000-12-26 |
Euro-Celtique, S.A. |
2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
|
|
AU706594B2
(en)
|
1995-11-06 |
1999-06-17 |
H. Lundbeck A/S |
Treatment of traumatic brain injury
|
|
US5800539A
(en)
|
1995-11-08 |
1998-09-01 |
Emory University |
Method of allogeneic hematopoietic stem cell transplantation without graft failure or graft vs. host disease
|
|
ZA969485B
(en)
|
1995-11-16 |
1998-05-12 |
Lilly Co Eli |
Excitatory amino acid receptor antagonists.
|
|
US5912248A
(en)
|
1995-11-16 |
1999-06-15 |
Eli Lilly And Company |
Excitatory amino acid receptor antagonists
|
|
US5688826A
(en)
|
1995-11-16 |
1997-11-18 |
Eli Lilly And Company |
Excitatory amino acid derivatives
|
|
IT1276153B1
(it)
|
1995-11-17 |
1997-10-27 |
Roberto Pellicciari |
Derivati di glicina ad attivita' antagonista dei recettori metabotropi del glutammato
|
|
GB9603723D0
(en)
|
1996-02-22 |
1996-04-24 |
Merck & Co Inc |
Diphenyl pyridyl derivatives as pde iv inhibitors
|
|
US5710170A
(en)
|
1995-12-15 |
1998-01-20 |
Merck Frosst Canada, Inc. |
Tri-aryl ethane derivatives as PDE IV inhibitors
|
|
GB9526245D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9526246D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9526243D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US5804686A
(en)
*
|
1996-01-19 |
1998-09-08 |
Neurogen Corporation |
fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
|
|
US6211365B1
(en)
|
1996-01-19 |
2001-04-03 |
Neurogen Corporation |
Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
|
|
EE03523B1
(et)
|
1996-01-31 |
2001-10-15 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
|
|
GB9604926D0
(en)
|
1996-03-08 |
1996-05-08 |
Sandoz Ltd |
Organic compounds
|
|
US5792766A
(en)
|
1996-03-13 |
1998-08-11 |
Neurogen Corporation |
Imidazo 1,5-c! quinazolines; a new class of GABA brain receptor ligands
|
|
WO1997034870A1
(en)
*
|
1996-03-22 |
1997-09-25 |
Neurogen Corporation |
Certain fused pyrrolecarboxamides as gaba brain receptor ligands
|
|
US5677309A
(en)
|
1996-03-22 |
1997-10-14 |
Neurogen Corporation |
1,2,4-triazolo 4,3-c! quinazolin-3-ones and 1,2,4-triazolo 4,3-c!quinazolin-3-thiones; a new class of GABA brain receptor ligands
|
|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US6127378A
(en)
|
1996-03-26 |
2000-10-03 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Phenanthridines substituted in the 6 position
|
|
FR2746800B1
(fr)
|
1996-03-29 |
1998-06-05 |
Jouveinal Inst Rech |
Diazepino-indoles inhibiteurs de phosphodiesterases 4
|
|
US6297273B1
(en)
|
1996-04-02 |
2001-10-02 |
Mars, Inc. |
Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
|
|
FR2754260B1
(fr)
|
1996-10-04 |
1998-10-30 |
Adir |
Nouveaux derives substitues de biphenyle ou de phenylpyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US5723462A
(en)
*
|
1996-04-26 |
1998-03-03 |
Neurogen Corporation |
Certain fused pyrrolecarboxamides a new class of GABA brain receptor ligands
|
|
AP2001002304A0
(en)
|
1996-05-03 |
2001-12-31 |
Pfizer |
Substituted indazole derivatives and related compounds
|
|
ATE215950T1
(de)
|
1996-05-10 |
2002-04-15 |
Icos Corp |
Carbolinderivate
|
|
NZ332341A
(en)
|
1996-05-20 |
2000-05-26 |
Darwin Discovery Ltd |
Quinoline carboxamides as TNF inhibitors and as PDE-IV inhibitors
|
|
HUP0100042A3
(en)
|
1996-05-20 |
2003-01-28 |
Darwin Discovery Ltd Cambridge |
Benzofuran carboxamides medicaments containing the same and their therapeutic use
|
|
JP2000510866A
(ja)
|
1996-05-20 |
2000-08-22 |
ダーウィン・ディスカバリー・リミテッド |
Tnfとpde―ivのインヒビターとしてのキノリンスルホンアミド
|
|
CA2258728C
(en)
|
1996-06-19 |
2011-09-27 |
Rhone Poulenc Rorer Limited |
Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
|
|
PL330974A1
(en)
|
1996-06-25 |
1999-06-21 |
Pfizer |
Substituted derivatives of indazole and their application as inhibitors of phosphodiesterase (pde) of iv type and of tumor necrosis factor (tnf)
|
|
US6017924A
(en)
|
1996-06-27 |
2000-01-25 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
|
EP0913389A4
(en)
|
1996-06-28 |
2000-02-02 |
Nippon Chemiphar Co |
CYCLOPROPYLGLYCINE DERIVATIVES AND AGONISTS OF THE L-GLUTAMATE RECEPTOR TYPE OF METABOLITE REGULATION
|
|
GB9614718D0
(en)
|
1996-07-12 |
1996-09-04 |
Bayer Ag |
3-ureido-pyridofurans and -pyridothiophenes
|
|
DE19628621A1
(de)
|
1996-07-16 |
1998-01-22 |
Byk Gulden Lomberg Chem Fab |
Neue 4-substituierte Benzofurane
|
|
EP0915875B1
(en)
|
1996-07-25 |
2003-04-09 |
MERCK SHARP & DOHME LTD. |
Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
|
|
US20020127271A1
(en)
|
1996-07-25 |
2002-09-12 |
Smithkline Beecham P.L.C. |
Formulation for the treatment and/or prophylaxis of dementia
|
|
EP0915877A1
(en)
|
1996-07-25 |
1999-05-19 |
MERCK SHARP & DOHME LTD. |
SUBSTITUTED TRIAZOLO PYRIDAZINE DERIVATIVES AS INVERSE AGONISTS OF THE GABA A?$g(a)5 RECEPTOR SUBTYPE
|
|
AU3967297A
(en)
|
1996-08-01 |
1998-02-25 |
Cocensys, Inc. |
Use of gaba and nmda receptor ligands for the treatment of migraine headache
|
|
PT956865E
(pt)
|
1996-08-12 |
2007-07-30 |
Mitsubishi Pharma Corp |
Medicamentos compreendendo inibidores da rho cinase.
|
|
DE19632549A1
(de)
|
1996-08-13 |
1998-02-19 |
Merck Patent Gmbh |
Arylalkanoylpyridazine
|
|
ES2188983T4
(es)
|
1996-08-19 |
2004-06-01 |
Altana Pharma Ag |
Nuevas benzofuran-4-carboxamidas.
|
|
ES2208950T3
(es)
|
1996-08-26 |
2004-06-16 |
Altana Pharma Ag |
Nuevos derivados de tiazol con un efecto inhibidor de fosfodiesterasas.
|
|
US6312753B1
(en)
|
1996-09-06 |
2001-11-06 |
Mars, Incorporated |
Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses
|
|
US6015913A
(en)
|
1996-09-06 |
2000-01-18 |
Mars, Incorporated |
Method for producing fat and/or solids from cocoa beans
|
|
US20010003588A1
(en)
|
1996-09-12 |
2001-06-14 |
Smithkline Beecham Corporation |
Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2.]oct-3-yl)acetonitrile monohydrochloride
|
|
ATE236884T1
(de)
|
1996-10-02 |
2003-04-15 |
Janssen Pharmaceutica Nv |
Pde-iv hemmende 2-cyanoiminoimidazol-derivate
|
|
WO1998016528A1
(en)
|
1996-10-11 |
1998-04-23 |
Chiron Corporation |
Purine inhibitors of glycogen synthase kinase 3 (gsk3)
|
|
DE19642451A1
(de)
|
1996-10-15 |
1998-04-16 |
Merck Patent Gmbh |
Aminothiophencarbonsäureamide
|
|
GB9621789D0
(en)
|
1996-10-18 |
1996-12-11 |
Lilly Industries Ltd |
Pharmaceutical compounds
|
|
AU726447B2
(en)
*
|
1996-10-21 |
2000-11-09 |
Neurosearch A/S |
1-phenyl-benzimidazole compounds and their use as BAGA-A receptor modulators
|
|
GB9622386D0
(en)
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
|
US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
|
US6069151A
(en)
|
1996-11-06 |
2000-05-30 |
Darwin Discovery, Ltd. |
Quinolines and their therapeutic use
|
|
DE69723863T2
(de)
|
1996-11-06 |
2004-04-15 |
Darwin Discovery Ltd., Slough |
Chinoline und deren therapeutische verwendung
|
|
JP2001504462A
(ja)
|
1996-11-12 |
2001-04-03 |
ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング |
ホスホジエステラーゼ阻害剤としての(2,3―ジヒドロベンゾフラニル)―チアゾール
|
|
JP2001505198A
(ja)
|
1996-11-20 |
2001-04-17 |
ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング |
Pde阻害剤としての置換ジヒドロベンゾフラン
|
|
GB9625184D0
(en)
|
1996-12-04 |
1997-01-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
SK283270B6
(sk)
|
1997-01-15 |
2003-04-01 |
Altana Pharma Ag |
Ftalazinóny, farmaceutické prostriedky s ich obsahom a ich použitie
|
|
GB9702524D0
(en)
|
1997-02-07 |
1997-03-26 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
PT975347E
(pt)
|
1997-02-28 |
2008-05-23 |
Nycomed Gmbh |
Combinação sinérgica de inibidores da pde e agonistas da adenilato ciclase ou agonistas da guanil ciclise
|
|
ES2131463B1
(es)
|
1997-04-08 |
2000-03-01 |
Lilly Sa |
Derivados de ciclopropilglicina con propiedades farmaceuticas.
|
|
GB9708945D0
(en)
|
1997-05-01 |
1997-06-25 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6387673B1
(en)
|
1997-05-01 |
2002-05-14 |
The Salk Institute For Biological Studies |
Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
|
|
US6043252A
(en)
|
1997-05-05 |
2000-03-28 |
Icos Corporation |
Carboline derivatives
|
|
WO1998050385A1
(en)
|
1997-05-08 |
1998-11-12 |
Merck Sharp & Dohme Limited |
SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
|
|
ZA983930B
(en)
|
1997-05-14 |
1999-11-08 |
Lilly Co Eli |
Excitatory amino acid receptor modulators.
|
|
DE69825605T2
(de)
|
1997-05-29 |
2005-09-15 |
H. Lundbeck A/S |
Behandlung der schizophrenie und der psychose
|
|
GB9713707D0
(en)
|
1997-06-27 |
1997-09-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6825211B1
(en)
|
1997-07-18 |
2004-11-30 |
Georgetown University |
Bicyclic metabotropic glutamate receptor ligands
|
|
JP2001515839A
(ja)
|
1997-07-18 |
2001-09-25 |
ジョージタウン・ユニバーシティ |
二環式向代謝性グルタミン酸受容体リガンド
|
|
PT1000035E
(pt)
|
1997-07-25 |
2003-04-30 |
Altana Pharma Ag |
6-fenilfenantridinas substituidas
|
|
GB9715977D0
(en)
|
1997-07-29 |
1997-10-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
ES2137113B1
(es)
|
1997-07-29 |
2000-09-16 |
Almirall Prodesfarma Sa |
Nuevos derivados de triazolo-piridazinas heterociclicos.
|
|
US6107295A
(en)
|
1997-08-01 |
2000-08-22 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Arylalkanoyl pyridazines
|
|
HUP0001054A3
(en)
|
1997-08-06 |
2001-01-29 |
Daiichi Asubio Pharma Co Ltd |
1-aryl-1,8-naphthyridin-4-one derivative as type iv phosphodiesterase inhibitor
|
|
US6143760A
(en)
|
1997-08-25 |
2000-11-07 |
Neurogen Corporation |
Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligands
|
|
US6207842B1
(en)
|
1997-10-09 |
2001-03-27 |
Mars Incorporated |
Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives
|
|
GB9721437D0
(en)
|
1997-10-10 |
1997-12-10 |
Glaxo Group Ltd |
Heteroaromatic compounds and their use in medicine
|
|
US6156753A
(en)
|
1997-10-28 |
2000-12-05 |
Vivus, Inc. |
Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
US6127363A
(en)
|
1997-10-28 |
2000-10-03 |
Vivus, Inc. |
Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
UA64769C2
(uk)
|
1997-11-07 |
2004-03-15 |
Х. Луннбек А/С |
Гідрогалогеніди 1'-[4-[1-(4-фторофеніл)-1н-індол-3-іл]-1-бутил]-спіро[ізобензофуран-1(3н),4'-піперидину], фармацевтична композиція та спосіб лікування
|
|
HU227841B1
(en)
|
1997-11-12 |
2012-05-02 |
Bayer Pharma AG |
2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof
|
|
WO1999025353A1
(en)
|
1997-11-13 |
1999-05-27 |
Merck Sharp & Dohme Limited |
Therapeutic uses of triazolo-pyridazine derivatives
|
|
US6429207B1
(en)
|
1997-11-21 |
2002-08-06 |
Nps Pharmaceuticals, Inc. |
Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
|
|
DE19882893T1
(de)
|
1997-12-12 |
2001-02-22 |
Euro Celtique Sa |
Herstellung von 3-substituierten Adeninen
|
|
IT1296985B1
(it)
|
1997-12-19 |
1999-08-03 |
Zambon Spa |
Derivati benzazinici inibitori della fosfodiesterasi 4
|
|
AU746866B2
(en)
|
1998-01-14 |
2002-05-02 |
Merck Sharp & Dohme Limited |
Triazolo-pyridazine derivatives as ligands for GABA receptors
|
|
GB9801208D0
(en)
*
|
1998-01-21 |
1998-03-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB9801210D0
(en)
|
1998-01-21 |
1998-03-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB9801202D0
(en)
|
1998-01-21 |
1998-03-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB9801234D0
(en)
|
1998-01-21 |
1998-03-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
MXPA00007135A
(es)
|
1998-01-21 |
2002-11-07 |
Merck Sharp & Dohme |
Derivados de triazolo-piridazina como ligandos para receptores gaba.
|
|
GB9801397D0
(en)
|
1998-01-22 |
1998-03-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
CA2285352A1
(en)
|
1998-01-29 |
1999-08-05 |
Suntory Limited |
1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phosphodiesterase iv inhibitory activity
|
|
US6103903A
(en)
|
1998-02-26 |
2000-08-15 |
Neurogen Corporation |
4-(4-piperidylmethyhlamino) substituted heteroaryl fused pyridines: GABA brain receptor ligands
|
|
AU2794099A
(en)
|
1998-02-26 |
1999-09-15 |
Neurogen Corporation |
Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
|
|
AU2793199A
(en)
|
1998-02-26 |
1999-09-15 |
Neurogen Corporation |
2-(het-)aryl-4-(cyclic amino substituted) heteroaryl fused pyridine derivatives,their preparation and their use as (ant-)agonists for gaba (a) brain receptors
|
|
AU2881199A
(en)
|
1998-02-26 |
1999-09-15 |
Neurogen Corporation |
Substituted 1,4-dihydro-4-oxonicotinic carboxamides: gaba brain receptor ligands
|
|
US6900228B1
(en)
|
1998-03-10 |
2005-05-31 |
Research Triangle Institute |
Opiate compounds, methods of making and methods of use
|
|
US6805883B2
(en)
|
1998-03-12 |
2004-10-19 |
Mars, Incorporated |
Food products containing polyphenol(s) and L-arginine to stimulate nitric oxide
|
|
AU758241B2
(en)
|
1998-03-13 |
2003-03-20 |
University Of British Columbia, The |
Granulatimide derivatives for use in cancer treatment
|
|
GB9806102D0
(en)
|
1998-03-20 |
1998-05-20 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
FR2776660B1
(fr)
|
1998-03-27 |
2000-05-12 |
Parke Davis |
Diazepino-indoles de phosphodiesterases iv
|
|
EP1071655A1
(en)
|
1998-04-17 |
2001-01-31 |
Kenneth Curry |
Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation
|
|
ES2203078T3
(es)
|
1998-04-20 |
2004-04-01 |
Pfizer Inc. |
Parazolopirimidinonas inhibidoras de gmpc pde5 para el tratamiento de la disfuncion sexual.
|
|
DK1076657T3
(da)
|
1998-04-28 |
2004-11-08 |
Elbion Ag |
Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling
|
|
CA2330738A1
(en)
|
1998-05-05 |
1999-11-11 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Novel n-oxides of benzonaphthyridines
|
|
WO1999059409A1
(en)
|
1998-05-21 |
1999-11-25 |
Matsumoto Rae R |
Compounds and uses thereof
|
|
US6897305B2
(en)
|
1998-06-08 |
2005-05-24 |
Theravance, Inc. |
Calcium channel drugs and uses
|
|
AU757198B2
(en)
|
1998-06-10 |
2003-02-06 |
Altana Pharma Ag |
Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
|
|
US6479506B1
(en)
|
1998-06-16 |
2002-11-12 |
Merck Sharp & Dohme Ltd. |
Triazolo-pyridine derivatives as ligands for GABA receptors
|
|
GB9813006D0
(en)
*
|
1998-06-16 |
1998-08-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
DE19826841A1
(de)
|
1998-06-16 |
1999-12-23 |
Merck Patent Gmbh |
Arylalkanoylpyridazine
|
|
DE69919707T2
(de)
|
1998-06-19 |
2005-09-01 |
Chiron Corp., Emeryville |
Glycogen synthase kinase 3 inhibitoren
|
|
AUPP438498A0
(en)
*
|
1998-06-29 |
1998-07-23 |
Garvan Institute Of Medical Research |
Novel Gaba-B receptor
|
|
DE69916066T2
(de)
|
1998-07-06 |
2005-02-24 |
Altana Pharma Ag |
Neue benzoxazole mit pde-hemmender wirkung
|
|
ITMI981671A1
(it)
|
1998-07-21 |
2000-01-21 |
Zambon Spa |
Derivati ftalazinici inibitori della fosfodisterasi 4
|
|
US6177569B1
(en)
|
1998-08-25 |
2001-01-23 |
Neurogen Corporation |
Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
|
|
EP1107738A4
(en)
|
1998-08-27 |
2003-01-22 |
Bristol Myers Squibb Co |
Novel pharmaceutical salt form
|
|
DE69918136T2
(de)
|
1998-08-31 |
2005-07-07 |
Taisho Pharmaceutical Co., Ltd. |
6-Fluorobicyclo[3.1.0]Hexan-Derivate
|
|
BR9913405A
(pt)
|
1998-09-03 |
2001-10-02 |
Kyowa Hakko Kogyo Kk |
Composto heterocìclico que contenha oxigênio, e, inibidor de fosfodiesterase (pde) iv.
|
|
CH694053A5
(de)
|
1998-09-03 |
2004-06-30 |
Hoffmann La Roche |
Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten.
|
|
WO2000015639A1
(en)
|
1998-09-16 |
2000-03-23 |
Icos Corporation |
Carboline derivatives as cgmp phosphodiesterase inhibitors
|
|
WO2000017184A1
(en)
|
1998-09-24 |
2000-03-30 |
Mitsubishi Chemical Corporation |
Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
|
|
AR023052A1
(es)
|
1998-09-25 |
2002-09-04 |
Mitsuharu Yoshimura Milton |
Derivados de pirimidona
|
|
JP2002527419A
(ja)
|
1998-10-08 |
2002-08-27 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
Gsk−3阻害物質としてのピロール−2,5−ジオン類
|
|
US6719520B2
(en)
|
1998-10-08 |
2004-04-13 |
Smithkline Beecham Corporation |
Method and compounds
|
|
DE69936998T2
(de)
|
1998-10-16 |
2008-05-21 |
Merck Sharp & Dohme Ltd., Hoddesdon |
Pyrazolotriazinderivate als gaba-rezeptorliganden
|
|
DE19850701A1
(de)
|
1998-11-04 |
2000-05-11 |
Merck Patent Gmbh |
Benzoylpyridazine
|
|
CA2349700A1
(en)
|
1998-11-12 |
2000-05-18 |
Merck & Co., Inc. |
Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
|
|
PE20001236A1
(es)
|
1998-11-13 |
2000-11-10 |
Lilly Co Eli |
Moduladores del receptor de aminoacidos excitadores
|
|
SE9804064D0
(sv)
|
1998-11-25 |
1998-11-25 |
A & Science Invest Ab |
Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
|
|
US6130333A
(en)
|
1998-11-27 |
2000-10-10 |
Monsanto Company |
Bicyclic imidazolyl derivatives as phosphodiesterase inhibitors, pharmaceutical compositions and method of use
|
|
US6414147B1
(en)
|
1998-12-23 |
2002-07-02 |
Neurogen Corporation |
2-amino-9-alkylpurines: GABA brain receptor ligands
|
|
GB9828640D0
(en)
|
1998-12-23 |
1999-02-17 |
Smithkline Beecham Plc |
Novel method and compounds
|
|
JP2002535407A
(ja)
|
1999-01-27 |
2002-10-22 |
メルク シャープ エンド ドーム リミテッド |
Gaba受容体のリガンドとしてのトリアゾロピリダジン誘導体
|
|
US6342496B1
(en)
|
1999-03-01 |
2002-01-29 |
Sepracor Inc. |
Bupropion metabolites and methods of use
|
|
US6498176B1
(en)
|
1999-03-04 |
2002-12-24 |
Smithklinebeecham Corporation |
3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors
|
|
TW575561B
(en)
|
1999-03-25 |
2004-02-11 |
Hoffmann La Roche |
1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives
|
|
DE19915365A1
(de)
|
1999-04-06 |
2000-10-12 |
Merck Patent Gmbh |
Tetrahydropyridazin-Derivate
|
|
JP5095050B2
(ja)
|
1999-04-28 |
2012-12-12 |
ジョージタウン ユニバーシティー |
代謝調節型グルタミン酸受容体のリガンド、及び、NAALADaseの阻害剤
|
|
US6528499B1
(en)
|
2000-04-27 |
2003-03-04 |
Georgetown University |
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
|
|
FR2792938B1
(fr)
|
1999-04-28 |
2001-07-06 |
Warner Lambert Co |
NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
|
|
US6943166B1
(en)
|
1999-04-30 |
2005-09-13 |
Lilly Icos Llc. |
Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction
|
|
US6737242B1
(en)
*
|
1999-05-07 |
2004-05-18 |
Neurogen Corporation |
Methods for screening GABA-modulatory compounds for specified pharmacological activities
|
|
US6316472B1
(en)
|
1999-05-13 |
2001-11-13 |
Merck Frosst Canada & Co. |
Heterosubstituted pyridine derivatives as PDE 4 inhibitors
|
|
US6448246B1
(en)
|
1999-05-25 |
2002-09-10 |
Neurogen Corporation |
Substituted 4H-1,4-benzothiazine-2-carboxamide: GABA brain receptor ligands
|
|
US6498180B1
(en)
|
1999-06-03 |
2002-12-24 |
Eli Lilly And Company |
Excitatory amino acid receptor modulators
|
|
US6906177B1
(en)
|
1999-06-10 |
2005-06-14 |
Takeda Chemical Industries, Ltd. |
GABA transporter protein and DNA thereof
|
|
US6146876A
(en)
|
1999-06-11 |
2000-11-14 |
Millennium Pharmaceuticals, Inc. |
22025, a novel human cyclic nucleotide phosphodiesterase
|
|
US6297256B1
(en)
|
1999-06-15 |
2001-10-02 |
Neurogen Corporation |
Aryl and heteroaryl substituted pyridino derivatives GABA brain receptor ligands
|
|
DE19928146A1
(de)
|
1999-06-19 |
2000-12-21 |
Merck Patent Gmbh |
Thienopyrimidine
|
|
FR2795724B1
(fr)
|
1999-07-02 |
2002-12-13 |
Sanofi Synthelabo |
Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant
|
|
TR200200161T2
(tr)
|
1999-07-21 |
2002-05-21 |
Fujisawa Pharmaceutical Co. Ltd. |
Benzimidazol türevleri ve onların fosfodiesteraz olarak kullanımı.
|
|
GB9918180D0
(en)
|
1999-08-02 |
1999-10-06 |
Smithkline Beecham Plc |
Novel compositions
|
|
US6821975B1
(en)
|
1999-08-03 |
2004-11-23 |
Lilly Icos Llc |
Beta-carboline drug products
|
|
US20050137206A1
(en)
|
1999-08-05 |
2005-06-23 |
Yevich Joseph P. |
Method for treatment of anxiety and depression
|
|
ES2209728T3
(es)
|
1999-08-06 |
2004-07-01 |
F. Hoffmann-La Roche Ag |
Tetrahidro-benzo(d)azepinas y su uso como antagonistas de receptores de glutamato metabotropico.
|
|
US6476019B1
(en)
|
1999-08-13 |
2002-11-05 |
Sepracor Inc. |
Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof
|
|
US6660753B2
(en)
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
EP1210118B1
(en)
*
|
1999-08-20 |
2004-12-08 |
Ortho-McNeil Pharmaceutical, Inc. |
Composition comprising a tramadol material and an anticonvulsant drug
|
|
US6313159B1
(en)
|
1999-08-20 |
2001-11-06 |
Guilford Pharmaceuticals Inc. |
Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors
|
|
GB9919957D0
(en)
|
1999-08-23 |
1999-10-27 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6566372B1
(en)
|
1999-08-27 |
2003-05-20 |
Ligand Pharmaceuticals Incorporated |
Bicyclic androgen and progesterone receptor modulator compounds and methods
|
|
EP1212322A2
(en)
|
1999-08-27 |
2002-06-12 |
Ligand Pharmaceuticals Incorporated |
8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators
|
|
MXPA02002032A
(es)
|
1999-08-27 |
2003-05-19 |
Ligand Pharm Inc |
Compuestos moduladores del receptor de androgeno y metodos.
|
|
US6956049B1
(en)
|
1999-08-31 |
2005-10-18 |
Merck & Co., Inc. |
Methods of modulating processes mediated by excitatory amino acid receptors
|
|
US20050014939A1
(en)
*
|
1999-08-31 |
2005-01-20 |
Neurogen Corporation |
Fused pyrrolecarboxamides: GABA brain receptor ligands
|
|
GB9921150D0
(en)
*
|
1999-09-07 |
1999-11-10 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB9921351D0
(en)
|
1999-09-09 |
1999-11-10 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
CA2383466C
(en)
|
1999-09-16 |
2009-08-25 |
Tanabe Seiyaku Co., Ltd. |
Aromatic nitrogen-containing 6-membered cyclic compounds
|
|
TWI265925B
(en)
|
1999-10-11 |
2006-11-11 |
Pfizer |
Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
|
|
US6552016B1
(en)
|
1999-10-14 |
2003-04-22 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
AU779874B2
(en)
|
1999-10-15 |
2005-02-17 |
F. Hoffmann-La Roche Ag |
Benzodiazepine derivatives
|
|
US7491742B2
(en)
|
1999-10-21 |
2009-02-17 |
Merck Patent Gmbh |
Imidazole derivatives as phosphodiesterase VII inhibitors
|
|
AR029185A1
(es)
|
1999-10-25 |
2003-06-18 |
Yamanouchi Pharma Co Ltd |
Derivado de naftiridina
|
|
US6534287B1
(en)
|
1999-10-25 |
2003-03-18 |
Nps Pharmaceuticals, Inc. |
Human metabotropic glutamate receptor
|
|
DE19953025A1
(de)
|
1999-11-04 |
2001-05-10 |
Merck Patent Gmbh |
Pyrrolderivate als Phosphodiesterase VII-Hemmer
|
|
DE19953414A1
(de)
|
1999-11-06 |
2001-05-10 |
Merck Patent Gmbh |
Imidazopyridinderivate als Phospodiesterase VII-Hemmer
|
|
DE19954707A1
(de)
|
1999-11-13 |
2001-05-17 |
Merck Patent Gmbh |
Imidazolverbindungen als Phosphodiesterase VII-Hemmer
|
|
DE19955408A1
(de)
*
|
1999-11-18 |
2001-05-23 |
Bayer Ag |
GABA-B-Rezeptoren
|
|
FR2801216A1
(fr)
|
1999-11-23 |
2001-05-25 |
Centre Nat Rech Scient |
Utilisation de derives d'indirubine pour la fabrication de medicaments
|
|
KR20100035666A
(ko)
|
1999-11-23 |
2010-04-05 |
메틸진 인크. |
히스톤 디아세틸라제의 억제제
|
|
GB9927687D0
(en)
*
|
1999-11-23 |
2000-01-19 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
DE69912808T2
(de)
|
1999-12-08 |
2004-09-30 |
Centre National De La Recherche Scientifique (C.N.R.S.) |
Verwendung von Hymenialdisin und dessen Derivaten zur Herstellung therapeutischer Mittel
|
|
ATE261445T1
(de)
|
1999-12-08 |
2004-03-15 |
Grelan Pharmaceutical Co |
Neue 1,8-naphtyridin-2(1h)-on-derivate
|
|
AU1734401A
(en)
|
1999-12-09 |
2001-06-18 |
Mitsubishi Pharma Corporation |
Carboxyamido derivatives
|
|
US6376489B1
(en)
|
1999-12-23 |
2002-04-23 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
GB9929685D0
(en)
|
1999-12-15 |
2000-02-09 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6680336B2
(en)
|
1999-12-15 |
2004-01-20 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
GB9929687D0
(en)
*
|
1999-12-15 |
2000-02-09 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
ES2246927T3
(es)
|
1999-12-17 |
2006-03-01 |
Chiron Corporation |
Inhibidores biciclicos de glucogeno sintasa quinasa 3.
|
|
CN1272328C
(zh)
|
1999-12-17 |
2006-08-30 |
希龙公司 |
糖元合成酶激酶3的基于吡嗪的抑制剂
|
|
US6372777B1
(en)
|
1999-12-23 |
2002-04-16 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
US6313156B1
(en)
|
1999-12-23 |
2001-11-06 |
Icos Corporation |
Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
|
|
US6294561B1
(en)
|
1999-12-23 |
2001-09-25 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
US6362213B1
(en)
|
1999-12-23 |
2002-03-26 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
US6258833B1
(en)
|
1999-12-23 |
2001-07-10 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
US6348602B1
(en)
|
1999-12-23 |
2002-02-19 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
US6569885B1
(en)
|
1999-12-23 |
2003-05-27 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
GB0000564D0
(en)
*
|
2000-01-11 |
2000-03-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6586582B2
(en)
|
2000-01-18 |
2003-07-01 |
Lexicon Genetics Incorporated |
Human GABA receptor proteins and polynucleotides encoding the same
|
|
CZ20022413A3
(cs)
|
2000-01-31 |
2003-08-13 |
Pfizer Products Inc. |
Pyrimidinkarboxamidy užitečné jako inhibitory isozymů PDE4
|
|
JP2003523741A
(ja)
|
2000-02-01 |
2003-08-12 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
Bcl−2様ポリヌクレオチド、ポリペプチドおよび抗体
|
|
AU2001234420A1
(en)
|
2000-02-03 |
2001-08-14 |
Eli Lilly And Company |
Potentiators of glutamate receptors
|
|
US20010039275A1
(en)
|
2000-02-04 |
2001-11-08 |
Bowler Andrew Neil |
Use of 2,4-diaminothiazole derivatives
|
|
WO2001056567A1
(en)
|
2000-02-04 |
2001-08-09 |
Novo Nordisk A/S |
2,4-diaminothiazole derivatives and their use as glycogen synthase kinase-3 (gsk-3) inhibitors
|
|
GB0003254D0
(en)
|
2000-02-11 |
2000-04-05 |
Darwin Discovery Ltd |
Heterocyclic compounds and their therapeutic use
|
|
FR2804959B1
(fr)
|
2000-02-15 |
2006-04-28 |
Centre Nat Rech Scient |
Utilisation de derives de paullones pour la fabrication de medicaments
|
|
NZ521576A
(en)
|
2000-02-29 |
2005-06-24 |
Mitsubishi Pharma Corp |
Novel cyclic amide derivatives
|
|
GB0005700D0
(en)
|
2000-03-09 |
2000-05-03 |
Glaxo Group Ltd |
Therapy
|
|
AU2001239550A1
(en)
|
2000-03-23 |
2001-10-03 |
Takeda Chemical Industries Ltd. |
Furoisoquinoline derivatives, process for producing the same and use thereof
|
|
JP2005289808A
(ja)
|
2000-03-23 |
2005-10-20 |
Sanofi-Aventis |
3−置換−4−ピリミドン誘導体
|
|
EP1136482A1
(en)
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
2-Amino-3-(alkyl)-pyrimidone derivatives as GSK3beta inhibitors
|
|
WO2001070243A2
(en)
|
2000-03-23 |
2001-09-27 |
Nexell Therapeutics Inc. |
A method for treating early breast cancer
|
|
EP1136485A1
(en)
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
Aminophenyl pyrimidone derivatives
|
|
AU2001262150A1
(en)
|
2000-03-23 |
2001-10-03 |
Mitsubishi Pharma Corporation |
2-(nitrogen-heterocyclic)pyrimidone derivatives
|
|
WO2001070727A1
(en)
|
2000-03-23 |
2001-09-27 |
Sanofi-Synthelabo |
2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives
|
|
JP2003528074A
(ja)
|
2000-03-24 |
2003-09-24 |
メチルジーン インコーポレイテッド |
ヒストン脱アセチル化酵素の阻害剤
|
|
GB0007193D0
(en)
|
2000-03-25 |
2000-05-17 |
Univ Manchester |
Treatment of movrmrnt disorders
|
|
US6683192B2
(en)
|
2000-03-30 |
2004-01-27 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
GB0007842D0
(en)
|
2000-03-31 |
2000-05-17 |
Spruce Barbara |
Sigma receptor ligands and their medical uses
|
|
GB0008264D0
(en)
|
2000-04-04 |
2000-05-24 |
Smithkline Beecham Plc |
Novel method and compounds
|
|
GB0008696D0
(en)
*
|
2000-04-07 |
2000-05-31 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2001076507A2
(en)
|
2000-04-11 |
2001-10-18 |
The University Of Miami |
Use of oxygen carriers to improve grafted cell survival in neural transplantation
|
|
KR20030005280A
(ko)
|
2000-04-14 |
2003-01-17 |
마아즈, 인코오포레이티드 |
혈관의 건강을 개선하기 위한 조성물과 방법
|
|
CA2306170A1
(en)
|
2000-04-18 |
2001-10-18 |
Kenneth Curry |
Novel amino, carboxy derivatives of barbituric acid
|
|
WO2001081345A1
(en)
|
2000-04-20 |
2001-11-01 |
Mitsubishi Pharma Corporation |
Aromatic amide compounds
|
|
MXPA02011053A
(es)
|
2000-05-11 |
2004-08-19 |
Kenneth Curry |
Compuestos novedosos de carboxi amino espiro (2,4)heptano y derivados de los mismos.
|
|
DE60129222T2
(de)
|
2000-05-11 |
2008-03-06 |
Consejo Superior de Investigaciónes Científicas |
Heterocyclischen inhibitoren von glycogen synthase kinase gsk-3
|
|
UA72611C2
(uk)
|
2000-05-17 |
2005-03-15 |
Орто-Макнейл Фармацевтикал, Інк. |
Похідні заміщеного піролопіридинону, корисні як інгібітори фосфодіестерази
|
|
UA74826C2
(en)
|
2000-05-17 |
2006-02-15 |
Ortho Mcneil Pharm Inc |
?-carboline derivatives as phosphodiesterase inhibitors
|
|
WO2001089583A2
(en)
|
2000-05-23 |
2001-11-29 |
Neurologix, Inc. |
Glutamic acid decarboxylase (gad)_delivery system for treating neurodegenerative diseases
|
|
WO2001090108A1
(en)
|
2000-05-24 |
2001-11-29 |
Merck Sharp & Dohme Limited |
3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
|
|
AU781526B2
(en)
|
2000-05-30 |
2005-05-26 |
Societe Des Produits Nestle S.A. |
Primary composition containing a lipophilic bioactive compound
|
|
US7081481B2
(en)
|
2000-05-31 |
2006-07-25 |
Eli Lilly And Company |
Excitatory amino acid receptor modulators
|
|
CA2411013A1
(en)
|
2000-06-07 |
2001-12-13 |
Jose Manuel Prieto Soto |
6-phenylpyrrolopyrimidinedione derivatives
|
|
EP1294721B1
(en)
|
2000-06-23 |
2006-07-19 |
Lilly Icos LLC |
Cyclic gmp-specific phosphodiesterase inhibitors
|
|
US6589978B2
(en)
|
2000-06-30 |
2003-07-08 |
Hoffman-La Roche Inc. |
1-sulfonyl pyrrolidine derivatives
|
|
US6399641B1
(en)
|
2000-07-13 |
2002-06-04 |
Hoffmann-La Roche Inc. |
2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists
|
|
GB0018473D0
(en)
|
2000-07-27 |
2000-09-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
CA2417277A1
(en)
|
2000-07-27 |
2002-02-07 |
F. Hoffmann-La Roche Ag |
3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3.beta.
|
|
GT200100147A
(es)
|
2000-07-31 |
2002-06-25 |
|
Derivados de imidazol
|
|
EP1307201B1
(de)
|
2000-08-01 |
2004-11-24 |
Bayer HealthCare AG |
Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung
|
|
US6645990B2
(en)
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
|
IL154425A0
(en)
|
2000-08-24 |
2003-09-17 |
Univ Tennessee Res H Corp |
Selective androgen receptor modulators and methods of use thereof
|
|
DZ3398A1
(fr)
|
2000-08-31 |
2002-03-07 |
Pfizer Prod Inc |
Derives pyrazole et leur utilisation comme inhibiteurs des proteines kinases
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
DE60103909T2
(de)
|
2000-09-01 |
2005-09-22 |
Sanofi-Aventis |
2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on- und 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5 1honderivate
|
|
EP1184384A1
(en)
|
2000-09-01 |
2002-03-06 |
Sanofi-Synthelabo |
1-(Alkyl), 1-((heteroaryl)alkyl) and 1-((aryl)alkyl)-7-pyridin-4-ylimidazo(1,2a)pyrimidin-5(1H)-one derivatives
|
|
US6576644B2
(en)
|
2000-09-06 |
2003-06-10 |
Bristol-Myers Squibb Co. |
Quinoline inhibitors of cGMP phosphodiesterase
|
|
WO2002020495A2
(en)
|
2000-09-06 |
2002-03-14 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
|
WO2002022579A2
(en)
|
2000-09-11 |
2002-03-21 |
Sepracor, Inc. |
Antipsychotic sulfonamide-heterocycles, and methods of use thereof
|
|
US6613776B2
(en)
|
2000-09-15 |
2003-09-02 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
AU2001290912A1
(en)
|
2000-09-15 |
2002-03-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US6610677B2
(en)
|
2000-09-15 |
2003-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
BR0114080A
(pt)
|
2000-09-22 |
2003-07-29 |
Mars Uk Ltd |
Suplemento alimentìcio, uso do mesmo, método para auxiliar a prevenção ou tratamento de dano oxidativo, alimento, e, métodos para fabricar o mesmo, e para melhorar ou aumentar a produção de trabalho de um animal
|
|
CA2423868C
(en)
|
2000-09-29 |
2011-06-07 |
Prolifix Limited |
Carbamic acid compounds comprising an amide linkage as hdac inhibitors
|
|
GB0023983D0
(en)
|
2000-09-29 |
2000-11-15 |
Prolifix Ltd |
Therapeutic compounds
|
|
EP2292593A3
(en)
|
2000-09-29 |
2011-05-25 |
TopoTarget UK Limited |
Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
|
|
JP3830746B2
(ja)
|
2000-09-29 |
2006-10-11 |
スガツネ工業株式会社 |
ヒンジ装置
|
|
CN1703403A
(zh)
|
2000-10-02 |
2005-11-30 |
詹森药业有限公司 |
趋代谢的谷氨酸盐受体拮抗剂
|
|
EP1193261A1
(en)
|
2000-10-02 |
2002-04-03 |
Warner-Lambert Company |
New thiadiazoles and their use as phosphodiesterase-7 inhibitors
|
|
WO2002032896A1
(en)
|
2000-10-16 |
2002-04-25 |
Novo Nordisk A/S |
Furazanyl-triazole derivates for the treatment of diseases
|
|
US20020103192A1
(en)
|
2000-10-26 |
2002-08-01 |
Curtin Michael L. |
Inhibitors of histone deacetylase
|
|
AU1253002A
(en)
|
2000-11-10 |
2002-05-21 |
Merck Sharp & Dohme |
Imidazo-triazine derivatives as ligands for gaba receptors
|
|
GB0027561D0
(en)
|
2000-11-10 |
2000-12-27 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB0117277D0
(en)
|
2001-07-16 |
2001-09-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
NZ525147A
(en)
|
2000-11-14 |
2004-10-29 |
Altana Pharma Ag |
(Dihydro)isoquinoline derivatives as phosphodiesterase inhibitors
|
|
TWI239333B
(en)
|
2000-11-16 |
2005-09-11 |
Hoffmann La Roche |
Benzodiazepine derivatives as GABA A receptor modulators
|
|
AP2001002359A0
(en)
*
|
2000-11-30 |
2001-12-31 |
Pfizer Prod Inc |
Combination of gaba agonists and aldose reductase inhibitors.
|
|
AR035659A1
(es)
|
2000-12-07 |
2004-06-23 |
Hoffmann La Roche |
Hidroxiamidas de acido (1-oxo-1,2,3,4-tetrahidro-naftalen-2-il)-alcanoico, proceso para la manufactura de estos compuestos, composiciones farmaceuticas que contienen dichos compuestos y los usos de los mismos
|
|
US6930114B2
(en)
|
2000-12-13 |
2005-08-16 |
Bayer Pharmaceuticals Corporation |
Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors
|
|
US6900215B2
(en)
*
|
2000-12-15 |
2005-05-31 |
Merck Sharp & Dohme Ltd. |
Imidazo-pyrimidine derivatives as ligands for gaba receptors
|
|
US6562995B1
(en)
|
2000-12-21 |
2003-05-13 |
Beacon Laboratories, Inc. |
Delta dicarbonyl compounds and methods for using the same
|
|
BR0116493A
(pt)
|
2000-12-21 |
2003-09-30 |
Vertex Pharma |
Compostos de pirazol úteis como inibidores de proteìna cinase
|
|
US6720445B2
(en)
|
2000-12-21 |
2004-04-13 |
Beacon Laboratories, Inc. |
Acetyloxymethyl esters and methods for using the same
|
|
ATE297734T1
(de)
|
2000-12-22 |
2005-07-15 |
Hoffmann La Roche |
Tetrahydro-(benzo- oder thieno-)azepin-pyrazin und triazinderivative als mglur 1 antagonisten
|
|
AR035513A1
(es)
|
2000-12-23 |
2004-06-02 |
Hoffmann La Roche |
Derivados de tetrahidropiridina, proceso para prepararlos, composiciones farmaceuticas que los contienen, y uso de dichos compuestos en la preparacion de medicamentos
|
|
GR1003861B
(el)
|
2000-12-29 |
2002-04-11 |
|
Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa.
|
|
US6974824B2
(en)
|
2001-01-08 |
2005-12-13 |
Research Triangle Institute |
Kappa opioid receptor ligands
|
|
AR035417A1
(es)
|
2001-01-27 |
2004-05-26 |
Hoffmann La Roche |
Derivados triciclicos de lactama y sultama, procesos para su elaboracion, medicamentos que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos
|
|
CZ20031903A3
(cs)
|
2001-01-31 |
2004-07-14 |
Pfizer Products Inc. |
Amidové deriváty thiazolyl-, oxazolyl-, pyrrolyl- a imidazolyl karboxylových kyselin užitečné jako inhibitory isozymů PDE4
|
|
KR20030070150A
(ko)
|
2001-01-31 |
2003-08-27 |
화이자 프로덕츠 인크. |
Pde4 이소자임 억제제로서 유용한 에테르 유도체
|
|
WO2002060875A1
(en)
|
2001-01-31 |
2002-08-08 |
Pfizer Products Inc. |
Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
|
|
US6559159B2
(en)
|
2001-02-01 |
2003-05-06 |
Research Triangle Institute |
Kappa opioid receptor ligands
|
|
US6617357B2
(en)
|
2001-03-06 |
2003-09-09 |
Smithkline Beecham Corporation |
Compounds and their use as PDE inhibitors
|
|
US20020177594A1
(en)
|
2001-03-14 |
2002-11-28 |
Curtin Michael L. |
Inhibitors of histone deacetylase
|
|
WO2002076953A1
(en)
|
2001-03-21 |
2002-10-03 |
Warner-Lambert Company Llc |
New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
|
|
US6900329B2
(en)
|
2001-03-21 |
2005-05-31 |
Schering Corporation |
MCH antagonists and their use in the treatment of obesity
|
|
WO2002088079A2
(en)
|
2001-05-01 |
2002-11-07 |
Bristol-Myers Squibb Company |
Dual inhibitors of pde 7 and pde 4
|
|
GB0111191D0
(en)
|
2001-05-08 |
2001-06-27 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2002089782A2
(en)
|
2001-05-09 |
2002-11-14 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
|
PA8546001A1
(es)
|
2001-05-25 |
2003-12-30 |
Pfizer |
Un inhibidor de pde4 y un agente anticolinergico en combinacion para tratar enfermedades obstructivas de vias respiratorias
|
|
WO2002096423A2
(en)
|
2001-05-25 |
2002-12-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Combination of a pde4 inhibitor and tiotropium or derivate thereof for treating obstructive airways
|
|
MXPA03010961A
(es)
|
2001-05-31 |
2004-02-27 |
Vertex Pharma |
Compuestos de tiazol utiles como inhibidores de proteinas cinasas.
|
|
WO2002100848A1
(en)
|
2001-06-12 |
2002-12-19 |
Sk Corporation |
Novel phenylalkyl diamine and amide analogs
|
|
PE20030008A1
(es)
|
2001-06-19 |
2003-01-22 |
Bristol Myers Squibb Co |
Inhibidores duales de pde 7 y pde 4
|
|
CA2450934A1
(en)
|
2001-06-19 |
2002-12-27 |
Marco Dodier |
Pyrimidine inhibitors of phosphodiesterase (pde) 7
|
|
DE10130167A1
(de)
|
2001-06-22 |
2003-01-02 |
Bayer Ag |
Imidazotriazine
|
|
SE0102440D0
(sv)
|
2001-07-05 |
2001-07-05 |
Astrazeneca Ab |
New compound
|
|
GB0117060D0
(en)
|
2001-07-12 |
2001-09-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
JP2003029331A
(ja)
|
2001-07-13 |
2003-01-29 |
Sano Fuji Koki Co Ltd |
反射型液晶プロジェクタ
|
|
WO2003010161A1
(en)
|
2001-07-24 |
2003-02-06 |
Bristol-Myers Squibb Company |
S-6-hydroxy-buspirone
|
|
EP1417188A1
(en)
|
2001-08-03 |
2004-05-12 |
Novo Nordisk A/S |
Novel 2,4-diaminothiazole derivatives
|
|
EP1285922A1
(en)
|
2001-08-13 |
2003-02-26 |
Warner-Lambert Company |
1-Alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
|
|
JO2311B1
(en)
|
2001-08-29 |
2005-09-12 |
ميرك فروست كندا ليمتد |
Alkyl inhibitors Ariel phosphodiesterase-4
|
|
CA2465978C
(en)
|
2001-09-14 |
2015-04-07 |
Soon Hyung Woo |
Inhibitors of histone deacetylase
|
|
US6897220B2
(en)
|
2001-09-14 |
2005-05-24 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
EP1295884A1
(en)
|
2001-09-21 |
2003-03-26 |
Sanofi-Synthelabo |
2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 7-Pyrimidinyl-2,3-Dihydroimidazo[1,2-a]Pyrimidin-5(1H)one derivatives
|
|
BR0212896A
(pt)
|
2001-09-21 |
2004-10-13 |
Sanofi Synthelabo |
Derivados de 2-piridinil-6,7,8,9-tetrahidropirimido[1,2-a]pirimidin-4- ona e 7-piridinil-2,3dihidroimidazo[1,2-a] pirimidin-5(1h)ona substituìdos
|
|
EP1295885A1
(en)
|
2001-09-21 |
2003-03-26 |
Sanofi-Synthelabo |
Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1H)one derivatives
|
|
WO2003027115A1
(en)
|
2001-09-21 |
2003-04-03 |
Sanofi-Synthelabo |
Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders
|
|
DE10148618B4
(de)
|
2001-09-25 |
2007-05-03 |
Schering Ag |
Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
|
BR0212829A
(pt)
|
2001-09-26 |
2004-08-03 |
Bayer Pharmaceuticals Corp |
Derivados de 1,8-naftiridina e seu uso para tratar diabetes e distúrbios relacionados
|
|
WO2004089942A2
(en)
|
2001-10-02 |
2004-10-21 |
Acadia Pharmaceuticals Inc. |
Benzimidazolidinone derivatives as muscarinic agents
|
|
US6951849B2
(en)
|
2001-10-02 |
2005-10-04 |
Acadia Pharmaceuticals Inc. |
Benzimidazolidinone derivatives as muscarinic agents
|
|
RU2288919C2
(ru)
|
2001-10-02 |
2006-12-10 |
Акадиа Фармасьютикалз, Инк. |
Производные бензимидазолидинона в качестве агентов мускариновых рецепторов
|
|
US6924311B2
(en)
|
2001-10-17 |
2005-08-02 |
X-Ceptor Therapeutics, Inc. |
Methods for affecting various diseases utilizing LXR compounds
|
|
AU2002337956B2
(en)
|
2001-10-25 |
2006-02-23 |
Schering Corporation |
MCH Antagonists for the treatment of obesity
|
|
IL161662A0
(en)
|
2001-11-01 |
2004-09-27 |
Janssen Pharmaceutica Nv |
Heteroaryl amines as glycogen synthase kinase 3 beta inhibitors (gsk3 inhibitors)
|
|
AU2002363174B2
(en)
|
2001-11-01 |
2008-09-25 |
Janssen Pharmaceutica N.V. |
Amide derivatives as glycogen synthase kinase 3-beta inhibitors
|
|
HUP0402245A3
(en)
|
2001-11-01 |
2010-03-29 |
Janssen Pharmaceutica Nv |
Pyrimidinyl-aminobenzamide derivatives as glycogen synthase kinase 3betha inhibitors, their use, pharmaceutical compositions containing them and process for producing them
|
|
EP1448562B1
(en)
|
2001-11-14 |
2007-07-25 |
Ortho-Mcneil Pharmaceutical Corp. |
Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
|
|
GB0128287D0
(en)
|
2001-11-26 |
2002-01-16 |
Smithkline Beecham Plc |
Novel method and compounds
|
|
FR2832711B1
(fr)
|
2001-11-26 |
2004-01-30 |
Warner Lambert Co |
Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
|
|
AU2002365892A1
(en)
|
2001-11-30 |
2003-06-17 |
Merck & Co., Inc. |
Metabotropic glutamate receptor-5 modulators
|
|
WO2003053975A1
(en)
|
2001-12-13 |
2003-07-03 |
Daiichi Suntory Pharma Co., Ltd. |
Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
|
|
EP1458708B1
(en)
|
2001-12-18 |
2007-09-26 |
Merck & Co., Inc. |
Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
|
|
JP4286146B2
(ja)
|
2001-12-18 |
2009-06-24 |
メルク エンド カムパニー インコーポレーテッド |
メタボトロピックグルタミン酸受容体−5のヘテロアリール置換ピラゾール系調節剤
|
|
AU2002353186A1
(en)
|
2001-12-19 |
2003-06-30 |
Smithkline Beecham P.L.C. |
(1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors
|
|
EP1458385A4
(en)
|
2001-12-19 |
2005-12-21 |
Merck & Co Inc |
METABOTROPIC GLUTAMATE RECEPTOR 5-HETEROARYL-SUBSTITUTED IMIDAZOLE MODULATORS
|
|
SE0104341D0
(sv)
|
2001-12-20 |
2001-12-20 |
Astrazeneca Ab |
New use
|
|
SE0104340D0
(sv)
|
2001-12-20 |
2001-12-20 |
Astrazeneca Ab |
New compounds
|
|
AU2002359162A1
(en)
|
2001-12-21 |
2003-07-15 |
Astrazeneca Ab |
Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
|
|
JP4357965B2
(ja)
|
2001-12-21 |
2009-11-04 |
メルク エンド カムパニー インコーポレーテッド |
メタボトロピックグルタミン酸受容体−5のヘテロアリール置換ピロールモジュレーター
|
|
TW200301123A
(en)
|
2001-12-21 |
2003-07-01 |
Astrazeneca Uk Ltd |
New use
|
|
DE10163991A1
(de)
|
2001-12-24 |
2003-07-03 |
Merck Patent Gmbh |
Pyrrolo-pyrimidine
|
|
PL208123B1
(pl)
|
2001-12-27 |
2011-03-31 |
Taisho Pharmaceutical Co Ltd |
Pochodna kwasu 2-amino-3-alkoksy-6-fluorobicyklo [3.1.0] heksano-2, 6-dikarboksylowego, zawierająca ją kompozycja farmaceutyczna i lek, oraz jej zastosowanie
|
|
US7550459B2
(en)
|
2001-12-28 |
2009-06-23 |
Acadia Pharmaceuticals, Inc. |
Tetrahydroquinoline analogues as muscarinic agonists
|
|
NZ533567A
(en)
|
2001-12-28 |
2007-06-29 |
Acadia Pharm Inc |
Spiroazacyclic compounds as monoamine receptor for modulating 5-HT2A receptor-mediated events
|
|
AU2002359875B2
(en)
|
2001-12-28 |
2009-01-08 |
Acadia Pharmaceuticals Inc. |
Tetrahydroquinoline analogues as muscarinic agonists
|
|
EP1468684A4
(en)
|
2002-01-22 |
2008-02-27 |
Eisai R&D Man Co Ltd |
SIGMA RECEPTOR BINDING MOLECULE WITH INDANO DERIVATIVE
|
|
JPWO2003064389A1
(ja)
|
2002-01-31 |
2005-05-26 |
小野薬品工業株式会社 |
含窒素二環性化合物およびその化合物を有効成分として含有する薬剤
|
|
MXPA04007737A
(es)
|
2002-02-11 |
2004-10-15 |
Pfizer |
Derivados de nicotinamida utiles como inhibidores de fosfodesterasas 4.
|
|
AU2003245700A1
(en)
|
2002-02-12 |
2003-09-04 |
Glaxo Group Limited |
Pyrazolopyridine derivatives
|
|
AU2003211428A1
(en)
|
2002-02-22 |
2003-09-09 |
Teijin Limited |
Pyrrolopyrimidine derivative
|
|
TW200306191A
(en)
|
2002-02-22 |
2003-11-16 |
Teijin Ltd |
Pyrrolopyrimidine derivatives
|
|
AU2003221500B9
(en)
|
2002-02-28 |
2008-11-20 |
Mitsubishi Pharma Corporation |
Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl -6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives
|
|
EP1340759A1
(en)
|
2002-02-28 |
2003-09-03 |
Sanofi-Synthelabo |
1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives
|
|
ES2276048T3
(es)
|
2002-03-05 |
2007-06-16 |
Eli Lilly And Company |
Derivados de purina como inhibidores de cinasa.
|
|
ATE368657T1
(de)
|
2002-03-08 |
2007-08-15 |
Lilly Co Eli |
Pyrrol-2,5-dion derivate und deren verwendung als gsk-3 inhibitoren
|
|
JP2005526765A
(ja)
|
2002-03-11 |
2005-09-08 |
シエーリング アクチエンゲゼルシャフト |
Cdk−阻害性2−ヘテロアリール−ピリミジン類、それらの生成及び医薬としての使用
|
|
EP1485093B1
(en)
|
2002-03-12 |
2010-11-03 |
Merck Sharp & Dohme Corp. |
Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
|
|
ES2306859T3
(es)
|
2002-03-13 |
2008-11-16 |
Janssen Pharmaceutica Nv |
Derivados de sulfonil como nuevos inhibidores de histona deacetilasa.
|
|
CN100396679C
(zh)
|
2002-03-13 |
2008-06-25 |
詹森药业有限公司 |
用作组蛋白脱乙酰化酶抑制剂的哌嗪基、哌啶基和吗啉基衍生物
|
|
WO2003076401A1
(en)
|
2002-03-13 |
2003-09-18 |
Janssen Pharmaceutica N.V. |
Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
|
|
CA2476583C
(en)
|
2002-03-13 |
2011-07-05 |
Kristof Van Emelen |
Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
|
|
ES2284739T3
(es)
|
2002-03-20 |
2007-11-16 |
Societe Des Produits Nestle S.A. |
Extracto de cacao con bajo contenido en grasa.
|
|
GB0206723D0
(en)
|
2002-03-21 |
2002-05-01 |
Glaxo Group Ltd |
Novel compounds
|
|
US7514107B2
(en)
|
2002-03-21 |
2009-04-07 |
Mars, Incorporated |
Treatment of diseases involving defective gap junctional communication
|
|
GB0207246D0
(en)
|
2002-03-27 |
2002-05-08 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0207249D0
(en)
|
2002-03-27 |
2002-05-08 |
Glaxo Group Ltd |
Novel compounds
|
|
SE0302546D0
(sv)
|
2003-09-24 |
2003-09-24 |
Astrazeneca Ab |
New compounds
|
|
SE0200979D0
(sv)
|
2002-03-28 |
2002-03-28 |
Astrazeneca Ab |
New compounds
|
|
AR039209A1
(es)
|
2002-04-03 |
2005-02-09 |
Novartis Ag |
Derivados de indolilmaleimida
|
|
NZ536116A
(en)
|
2002-04-03 |
2007-01-26 |
Topotarget Uk Ltd |
Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
|
|
SE0201194D0
(sv)
|
2002-04-19 |
2002-04-19 |
Astrazeneca Ab |
New compounds
|
|
GB0210124D0
(en)
|
2002-05-02 |
2002-06-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
CA2485527A1
(en)
|
2002-05-08 |
2003-11-20 |
Janssen Pharmaceutica N.V. |
Substituted pyrroline kinase inhibitors
|
|
GB0212048D0
(en)
|
2002-05-24 |
2002-07-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
JP2005531609A
(ja)
|
2002-06-05 |
2005-10-20 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
キナーゼ阻害剤としてのシスインドリル−マレイミド誘導体
|
|
ES2312785T3
(es)
|
2002-06-05 |
2009-03-01 |
Janssen Pharmaceutica Nv |
Pirrolinas sustituidas utiles como inhibidores de quinasa.
|
|
CA2490239C
(en)
|
2002-06-19 |
2011-05-24 |
Janssen Pharmaceutica N.V. |
Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
|
|
SI2256108T1
(sl)
|
2002-07-18 |
2016-05-31 |
Janssen Pharmaceutica N.V. |
Substituirani triazinski kinazni inhibitorji
|
|
MXPA05000827A
(es)
|
2002-07-19 |
2005-08-29 |
Memory Pharm Corp |
Inhibidores de fosfodiesterasa 4, incluyendo analogos de anilina y difenilamina n-sustituidos.
|
|
JP2005536517A
(ja)
|
2002-07-23 |
2005-12-02 |
スミスクライン ビーチャム コーポレーション |
キナーゼインヒビターとしてのピラゾロピリミジン
|
|
EP1534389A2
(en)
|
2002-07-23 |
2005-06-01 |
SmithKline Beecham Corporation |
Pyrazolopyrimidines as kinase inhibitors
|
|
WO2004009597A2
(en)
|
2002-07-23 |
2004-01-29 |
Smithkline Beecham Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
|
MXPA05001367A
(es)
|
2002-08-02 |
2005-04-28 |
Vertex Pharma |
Composiciones de pirazol utiles como inhibidores de gsk-3.
|
|
DE10239042A1
(de)
|
2002-08-21 |
2004-03-04 |
Schering Ag |
Makrozyclische Pyrimidine, deren Herstellung und Verwendung als Arzneimittel
|
|
JP4881558B2
(ja)
|
2002-09-04 |
2012-02-22 |
シェーリング コーポレイション |
サイクリン依存性キナーゼインヒビターとしてのピラゾロピリミジン
|
|
DE60313872T2
(de)
|
2002-09-04 |
2008-01-17 |
Schering Corp. |
Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen
|
|
EP1400244A1
(en)
|
2002-09-17 |
2004-03-24 |
Warner-Lambert Company LLC |
New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
|
|
CA2500587A1
(en)
|
2002-10-04 |
2004-04-22 |
The Regents Of The University Of California |
Screening and therapeutic methods relating to neurogenesis
|
|
CN1717391A
(zh)
|
2002-10-21 |
2006-01-04 |
希龙公司 |
糖元合成酶激酶3的抑制剂
|
|
GB0226583D0
(en)
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Compounds
|
|
FR2847253B1
(fr)
|
2002-11-19 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
US6969702B2
(en)
|
2002-11-20 |
2005-11-29 |
Neuronova Ab |
Compounds and methods for increasing neurogenesis
|
|
US20050009847A1
(en)
|
2002-11-20 |
2005-01-13 |
Goran Bertilsson |
Compounds and methods for increasing neurogenesis
|
|
US20040185429A1
(en)
|
2002-12-09 |
2004-09-23 |
Judith Kelleher-Andersson |
Method for discovering neurogenic agents
|
|
ES2209650B2
(es)
|
2002-12-09 |
2006-11-01 |
Laboratorios Del Dr. Esteve, S.A. |
Mamiferos no humanos mutantes deficientes en receptores sigma y sus aplicaciones.
|
|
GB0229581D0
(en)
|
2002-12-19 |
2003-01-22 |
Cyclacel Ltd |
Use
|
|
US7135493B2
(en)
|
2003-01-13 |
2006-11-14 |
Astellas Pharma Inc. |
HDAC inhibitor
|
|
WO2004065370A1
(en)
|
2003-01-23 |
2004-08-05 |
Crystalgenomics, Inc. |
Glycogen synthase kinase 3beta inhibitor, composition and process for the preparation thereof
|
|
MXPA05008186A
(es)
|
2003-01-31 |
2005-10-05 |
Astrazeneca Ab |
Derivados de quinoxalina saturados y su uso como ligandos receptores de glutamato metabotropico.
|
|
US6969716B2
(en)
|
2003-02-07 |
2005-11-29 |
Merck Sharp & Dohme Ltd. |
5-phenyl[1,2,4]triazines as ligands for GABA-A α2/α3 receptors for treating anxiety or depression
|
|
CA2515132C
(en)
|
2003-02-07 |
2012-01-03 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl substituted pyrroles useful as inhibitors of protein kinases
|
|
GB0303319D0
(en)
|
2003-02-13 |
2003-03-19 |
Novartis Ag |
Organic compounds
|
|
EP1454900A1
(en)
|
2003-03-07 |
2004-09-08 |
Sanofi-Synthelabo |
Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto-esters
|
|
EP1454909B1
(en)
|
2003-03-07 |
2008-08-20 |
Sanofi Aventis |
8'-pyridinyl-dihydrospiro- (cycloalkyl) -pyrimido (1,2-a) pyrimidin-6-one and 8'-pyrimidinyl-dihydrospiro (cycloalkyl) -pyrimido (1,2-a) pyrimidin-6-one derivatives and their use against neurodegenerative diseases
|
|
EP1454910A1
(en)
|
2003-03-07 |
2004-09-08 |
Sanofi-Synthelabo |
Substituted pyrimidinyl-2-(diaza-bicyclo-alkyl)-pyrimidone derivatives
|
|
EP1454908B1
(en)
|
2003-03-07 |
2008-02-27 |
Sanofi-Aventis |
Substituted pyridinyl-2-(diaza-bicyclo-alkyl)-pyrimidinone derivatives
|
|
TWI292318B
(en)
|
2003-03-10 |
2008-01-11 |
Hoffmann La Roche |
Imidazol-4-yl-ethynyl-pyridine derivatives
|
|
US20050037983A1
(en)
*
|
2003-03-11 |
2005-02-17 |
Timothy Dinan |
Compositions and methods for the treatment of depression and other affective disorders
|
|
US7375228B2
(en)
|
2003-03-17 |
2008-05-20 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
EP1460076A1
(en)
|
2003-03-21 |
2004-09-22 |
Sanofi-Synthelabo |
Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives
|
|
EP1613629A1
(en)
|
2003-03-27 |
2006-01-11 |
Pfizer Products Inc. |
Substituted 4-amino 1,2,4 triazolo 4,3-a quinoxalines
|
|
CN1777425A
(zh)
|
2003-03-28 |
2006-05-24 |
阿卡蒂亚药品公司 |
用于疼痛控制的毒蕈碱性m1受体激动剂
|
|
CA2519379A1
(en)
|
2003-04-04 |
2004-10-21 |
Dynogen Pharmaceuticals, Inc. |
Method of treating lower urinary tract disorders
|
|
DE10316136A1
(de)
|
2003-04-09 |
2004-11-18 |
Ixys Semiconductor Gmbh |
Gekapselte Leistungshalbleiteranordnung
|
|
US7696198B2
(en)
|
2003-04-16 |
2010-04-13 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 4 inhibitors
|
|
WO2004093802A2
(en)
|
2003-04-17 |
2004-11-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Prevention of deficits in neurogenesis with anti-inflammatory agents
|
|
US7855212B2
(en)
|
2003-05-08 |
2010-12-21 |
Merck Serono Sa |
Pyridinyl acetonitriles
|
|
GB0311859D0
(en)
|
2003-05-22 |
2003-06-25 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2004106343A2
(en)
|
2003-05-30 |
2004-12-09 |
Ufc Limited |
Agelastatin derivatives of antitumour and gsk-3beta-inhibiting alkaloids
|
|
US7763588B2
(en)
|
2003-06-13 |
2010-07-27 |
The Salk Institute For Biological Studies |
Method for increasing cognitive function and neurogenesis
|
|
DE10328993A1
(de)
|
2003-06-27 |
2005-01-20 |
Bayer Materialscience Ag |
Blockierte Polyisocyanate
|
|
DK1641454T3
(da)
|
2003-06-27 |
2009-02-09 |
Pfizer Prod Inc |
Pyrazolo[3,4-B]pyridin-6-oner som GSK-3-hæmmere
|
|
CA2525245C
(en)
|
2003-06-27 |
2010-10-19 |
Pfizer Products Inc. |
Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors
|
|
GB0315657D0
(en)
|
2003-07-03 |
2003-08-13 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
|
US7842835B2
(en)
|
2003-07-07 |
2010-11-30 |
Georgetown University |
Histone deacetylase inhibitors and methods of use thereof
|
|
GB0315966D0
(en)
|
2003-07-08 |
2003-08-13 |
Cyclacel Ltd |
Compounds
|
|
NZ545058A
(en)
|
2003-07-16 |
2008-05-30 |
Janssen Pharmaceutica Nv |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
|
|
ES2317031T3
(es)
|
2003-07-16 |
2009-04-16 |
Janssen Pharmaceutica Nv |
Derivados de triazolopirimidina como inhibidores de la glucogeno-sintasa-quinasa 3.
|
|
EP2256106B1
(en)
|
2003-07-22 |
2015-05-06 |
Astex Therapeutics Limited |
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
|
|
PL1651234T3
(pl)
|
2003-07-25 |
2008-02-29 |
Hoffmann La Roche |
Kompozycja antagonisty mGluR2 i inhibitora AChE do leczenia ostrych i/lub przewlekłych zaburzeń neurologicznych
|
|
JP2007500178A
(ja)
|
2003-07-30 |
2007-01-11 |
サイクラセル・リミテッド |
プロテインキナーゼ阻害剤としてのピリジニルアミノ−ピリミジン誘導体
|
|
EP1648875A1
(en)
|
2003-07-30 |
2006-04-26 |
Cyclacel Limited |
2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
|
|
JP2007519393A
(ja)
|
2003-08-05 |
2007-07-19 |
ユニバーシティー オブ フロリダ リサーチ ファンデーション, インク. |
神経系細胞アッセイ
|
|
CN1871240B
(zh)
|
2003-08-26 |
2012-11-07 |
帝人制药株式会社 |
吡咯并嘧啶酮衍生物
|
|
US7820439B2
(en)
*
|
2003-09-03 |
2010-10-26 |
Reliance Life Sciences Pvt Ltd. |
In vitro generation of GABAergic neurons from pluripotent stem cells
|
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
|
EP1668004A1
(en)
|
2003-09-12 |
2006-06-14 |
Applied Research Systems ARS Holding N.V. |
Benzoxazole acetonitriles
|
|
HRP20070527T3
(en)
|
2003-09-12 |
2007-12-31 |
Laboratoires Serono Sa |
Benzothiazole derivatives for the treatment of diabetes
|
|
WO2005026155A1
(en)
|
2003-09-12 |
2005-03-24 |
Applied Research Systems Ars Holding N.V. |
Benzimidazole acetonitriles
|
|
MXPA06004043A
(es)
|
2003-10-10 |
2006-06-28 |
Pfizer Prod Inc |
2h-[1,2,4]triazolo[4,3-a]pirazinas sustituidas como inhibidores de la glucogeno sintetasa cinasa 3.
|
|
RU2006115615A
(ru)
|
2003-10-10 |
2007-11-27 |
Марс, Инкорпорейтед (Us) |
Лечение заболеваний, в патогенез которых вовлечена гиперэкспрессия киназы erbb2
|
|
DE10349423A1
(de)
|
2003-10-16 |
2005-06-16 |
Schering Ag |
Sulfoximinsubstituierte Parimidine als CDK- und/oder VEGF-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
|
|
BRPI0415759A
(pt)
|
2003-10-21 |
2006-12-19 |
Cyclacel Ltd |
compostos de pirimidin-4-il-3,4-tiona e uso dos mesmos na terapia
|
|
CA2547283C
(en)
|
2003-11-26 |
2010-11-09 |
Pfizer Products Inc. |
Aminopyrazole derivatives as gsk-3 inhibitors
|
|
US7855195B2
(en)
|
2003-12-02 |
2010-12-21 |
Pharmaneuroboost N.V. |
Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
|
|
US20050137234A1
(en)
|
2003-12-19 |
2005-06-23 |
Syrrx, Inc. |
Histone deacetylase inhibitors
|
|
WO2005065681A1
(en)
|
2003-12-19 |
2005-07-21 |
Takeda San Diego, Inc. |
N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer
|
|
BRPI0417749A
(pt)
|
2003-12-22 |
2007-04-10 |
Acadia Pharm Inc |
composto, método de sintese de composto, bibliotecas combinatórias, composições farmacêuticas e métodos de tratamento de disfunções neuropsiquiátricas
|
|
AU2005209908A1
(en)
|
2004-01-30 |
2005-08-18 |
Mars, Incorporated |
Methods and compositions for treating cancer
|
|
TWI301760B
(en)
|
2004-02-27 |
2008-10-11 |
Merz Pharma Gmbh & Co Kgaa |
Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
|
|
US7705017B2
(en)
|
2004-05-03 |
2010-04-27 |
En Vivo Pharmaceuticals, Inc. |
Compounds for treatment of neurodegenerative diseases
|
|
EP2021000A2
(en)
*
|
2006-05-09 |
2009-02-11 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|